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Exposure to water-damaged buildings and the associated health problems have evoked
concern and created confusion during the past 20 years. Individuals exposed to moisture
problem buildings report adverse health effects such as non-specific respiratory
symptoms. Microbes, especially fungi, growing on the damp material have been
considered as potential sources of the health problems encountered in these buildings.
Fungi and their airborne fungal spores contain allergens and secondary metabolites which
may trigger allergic as well as inflammatory types of responses in the eyes and airways.
Although epidemiological studies have revealed an association between damp buildings
and health problems, no direct cause-and-effect relationship has been established. Further
knowledge is needed about the epidemiology and the mechanisms leading to the
symptoms associated with exposure to fungi.
Two different approaches have been used in this thesis in order to investigate the
diverse health effects associated with exposure to moulds. In the first part, sensitization to
moulds was evaluated and potential cross-reactivity studied in patients attending a hospital
for suspected allergy. In the second part, one typical mould known to be found in water-
damaged buildings and to produce toxic secondary metabolites was used to study the
airway responses in an experimental model. Exposure studies were performed on both
naive and allergen sensitized mice.
The first part of the study showed that mould allergy is rare and highly dependent on
the atopic status of the examined individual. The prevalence of sensitization was 2.7% to
Cladosporium herbarum and 2.8% to Alternaria alternata in patients, the majority of
whom were atopic subjects.  Some of the patients sensitized to mould suffered from atopic
eczema. Frequently the patients were observed to possess specific serum IgE antibodies to
a yeast present in the normal skin flora, Pityrosporum ovale. In some of these patients, the
IgE binding was partly found to be due to binding to shared glycoproteins in the mould
and yeast allergen extracts. The second part of the study revealed that exposure to
Stachybotrys chartarum spores induced an airway inflammation in the lungs of mice. The
inflammation was characterized by an influx of inflammatory cells, mainly neutrophils
and lymphocytes, into the lungs but with almost no differences in airway responses seen
between the satratoxin producing and non-satratoxin producing strain. On the other hand,
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when mice were exposed to S. chartarum and sensitized/challenged with ovalbumin the
extent of the inflammation was markedly enhanced. A synergistic increase in the numbers
of inflammatory cells was seen in BAL and severe inflammation was observed in the
histological lung sections.
In conclusion, the results in this thesis imply that exposure to moulds in water
damaged buildings may trigger health effects in susceptible individuals. The symptoms
can  rarely  be  explained  by  IgE  mediated  allergy  to  moulds.  Other  non-allergic
mechanisms seem to be involved. Stachybotrys chartarum is one of the moulds potentially
responsible for health problems. In this thesis, new reaction models for the airway
inflammation induced by S. chartarum have been found using experimental approaches.
The immunological status played an important role in the airway inflammation, enhancing
the effects of mould exposure. The results imply that sensitized individuals may be more
susceptible to exposure to moulds than non-sensitized individuals.
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4. INTRODUCTION
Individuals are being continually exposed to fungi, since these micro-organisms are an
important part of our natural environment. Airborne fungal spores are inhaled into the
airways or individuals may come into contact with them directly via the skin. Indoor
fungal spore levels normally reflect the outdoor levels and thus vary according to the
season (Burge 2002). The highest spore levels are observed in late summer and autumn in
Finland. However, under certain circumstances such as in water damaged buildings, the
growth of fungi on wet building material can be favoured and increased growth can occur
indoors (Li and Yang 2004). Later fungal species normally not found indoors, start to
grow on the wet material and this may give rise to health problems of inhabitants of these
buildings, varying from allergic types of symptoms in the upper and lower airways to
more diverse respiratory symptoms (Bush et al. 2006).
Fungi and fungal spores contain allergenic proteins and glycoproteins that can evoke
sensitization in susceptible individuals (Kurup et  al. 2000). Sensitization to moulds has
been linked with an increased risk of developing allergic rhinitis and allergic asthma.
Fungi are allergenic to varying degrees depending on the species. Two of the most
common allergenic fungi tested in the clinic today are Alternaria alternata and
Cladosporium herbarum. A. alternata is  a worldwide sensitizer whereas C. herbarum is
more common in cooler climates. These fungi are commonly present in the outdoor air but
may occasionally also be found indoors.
Exposure to fungi may induce non-allergic, inflammatory airway responses. The
fungal cell wall consists of components known to trigger innate immune responses. In
addition,  some fungal species can produce potentially harmful secondary metabolites
(Assoulin-Daya et  al. 2002). For example, Stachybotrys chartarum is one of the fungal
species that has attracted attention due to its ability to produce highly toxic mycotoxins
(Hossain et al. 2004, Kuhn and Ghannoum 2003). Stachybotrys grows well on materials
containing wet cellulose and this micro-organism can occasionally be found in large
numbers in water damaged buildings. Stachybotrys has been linked to serious cases of
health problems in buildings where water damage has occurred.
Health problems associated with exposure to damp buildings has been responsible for
a greatdeal of alarm and concern. The users of these buildings experience a variety of
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symptoms but linking the symptoms to the use of a damp building has proved to be a
controversial task (Hardin et  al. 2003). Intensive investigations have been performed
during the last 20 years in order to identify the agents responsible for the problems as well
as clarifying the health effects or symptoms associated with the exposure (Terr 2004).
However, there is little hard evidence for direct cause-and-effect relationships between
exposure to damp buildings, the moulds and the health problems of the building
inhabitants (IOM 2004, Nevalainen and Seuri 2005). Few, if any, markers can be used to
assess exposure in the subjects residing in moisture problem buildings.
In an attempt to investigate the health effects associated with exposure to fungi or
moulds present in water-damaged buildings, we utilized two different approaches. The
prevalence for sensitization to moulds was assessed in patients attending a hospital for
suspected allergy. The prevalence for sensitization and IgE reactivity to two common
allergenic fungi (Alternaria alternata and Cladosporium herbarum) were evaluated. The
potential cross-reactivity for the IgE binding between mould and yeast allergen extracts
was further characterized. Direct airway effects of exposure to a common fungus often
detected in water-damaged buildings, namely Stachybotrys chartarum, were studied using
experimental models. Furthermore exposure to S. chartarum was  studied  together  with
experimental asthma in order to determine whether the immunological status has any
effect on the response.
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5. REVIEW OF THE LITERATURE
5.1. The immune response
The immune response against a foreign agent is commonly divided into innate immunity
and adaptive immunity (Janeway et al. 2005). Innate immunity is characterized by an
immediate attempt to eliminate the foreign agent by the host's defence system. The agent
is engulfed into specialized cells called phagocytes which then ingest and destroy the
agent. The adaptive immune response on the other hand is triggered when the innate
immune response fails to eliminate the pathogen. The adaptive immune response can more
specifically recognize virtually any foreign agent and in addition it leaves a pool of
memory cells which triggers a rapid release of inflammatory cells and mediators on a
second encounter with the antigen. Therefore, the adaptive immune response has been
considered as the more sophisticated system. In recent years however, it has been
recognized that a highly complex and specific system also underpins innate immunity.
5.1.1. Innate immunity
In innate immunity, the phagocytic cells hold in the key positions. The cells that play a
role are mainly dendritic cells, macrophages and granulocytic leucocytes such as
neutrophils. They provide the first line of defence against foreign agents such as microbes
invading the host, some of which might be pathogenic (Bals and Hiemstra 2004).
Pathogenic microbes are recognized by receptors on the phagocytosing cells, and then the
micro-organisms are engulfed by the cell and destroyed. The receptors on the cell surface
recognize and bind to conserved patterns or features common to pathogens. These
receptors include mannose, glucan and scavenger receptors on macrophages known to
bind to bacterial carbohydrates. Toll-like receptors (TLR), of which at least 10 functional
members have been identified, bind specifically to conserved bacterial, viral and fungal
components called pathogen associated molecular patterns (PAMPs) (Janssens and
Beyaert 2003). Binding leads to engulfment and digestion of the pathogen inside the cell
which triggers the release of inflammatory mediators such as cytokines and chemokines
and the activation of adhesion molecules. Chemokines recruit monocytes that rapidly
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differentiate into macrophages as well as attracting neutrophils to the site of inflammation.
Subsequently also lymphocytes and eosinophils may be activated to participate in the
immune response.
5.1.1.1. Inflammatory mediators
Cytokines are critical molecules involved in the signalling between the cells of the
immune system. Cytokines are small glycoproteins, including interleukins, interferons and
growth factors, produced by a variety of cells after activation. In a local inflammatory
response, the primary cytokines involved are the pro-inflammatory cytokines TNF- , IL-
 and IL-6 (Janeway et al. 2005). Activated macrophages are the primary cells secreting
TNF-  which is intended to provide local control of the inflammation. TNF-  along with
IL-1  and IL-6 are the main mediators of the acute phase of the inflammation (Dinarello
2000, Netea et al. 2002). Later in the response, other cytokines such as IL-12 may be
induced, leading to activation of yet more inflammatory cells. IL-12 favours the activation
of T cell differentiation into T helper 1 type, thus enlisting adaptive immunity into the
response. Early interferons such as IFN-  and -  are commonly activated in viral
infections while the later-appearing IFN, called IFN-  is involved in the acute immune
response to intracellular pathogens.
Chemokines are chemotactic molecules or ligands (L) attracting cells with appropriate
receptors (R) to migrate towards them (Luster 1998). Chemokines are divided into two
main  families  based  on  the  position  and  order  of  the  conserved  cysteine  (C)  amino  acid
residues in the molecule (Nickel et al. 1999). Chemokines involved in the recruitment of
monocytes belong to the so called C-C family of which CCL3/MIP-1 , CCL4/MIP-1  and
CCL2/MCP-1 are commonly known. Neutrophils are mainly attracted by chemokines
from the C-X-C family such as by CXCL8/IL-8 in humans and CXCL5/LIX and MIP-2 in
mice (Takaoka et al. 2001). CCL11/eotaxin-1 specifically recruits eosinophils while
lymphocytes are attracted by several chemokines which can also recruit monocytes to the
site of inflammation. The main chemokine receptors involved in innate immune responses
include CCR1 and CCR5 which are expressed on T cells, monocytes and dendritic cells.
Neutrophils  commonly  express  receptors  for  CXC  chemokines  of  which  CXCR2  is  the
most common. On the other hand, CCR3 is typically found on eosinophils.
13
5.1.2. Adaptive immunity
The innate immune system and its receptors cannot recognize all pathogens and the
adaptive immune system has developed to provide more specific recognition of a
particular pathogen or antigen (Clark and Kupper 2005). In adaptive immunity,
lymphocytes  play  a  major  role.   Lymphocytes  are  unique  in  their  ability  to  build  up  an
immune response which can recognize and respond specifically to virtually any foreign
antigen (Janeway et al. 2005).  When a lymphocyte recognizes its specific antigen, it is
activated and starts to differentiate. T-lymphocytes (thymus derived) differentiate into
effector cells and these cells take on many different functions after activation. B-
lymphocytes  (bone  marrow  derived)  on  the  other  hand  detect  antigens  outside  the  cells
and start to produce antibodies against the antigen when activated. In adaptive immunity,
the main features are the specificity of antigen recognition and memory. A subset of the
activated specific lymphocytes develops into memory cells that can readily respond to the
same antigen if it is encountered again (McHeyzer-Williams and McHeyzer-Williams
2005).
5.1.2.1. Antigen recognition
The immune response is initiated when an immature dendritic cell, which is the main
phagocytosing cell in adaptive immunity, locates a pathogen or antigen in infected tissue
and starts to ingest it. The dendritic cell becomes activated and matures into an antigen
presenting cell (APC). The APC carries the degraded antigen to the nearest lymph node
and effectively presents it to T-lymphocytes (von Bubnoff et al. 2001). The antigen is
presented via molecules on the surface of APCs called the major histocompatibility
complex (MHC). Peptides found in the cytosol of the APC such as viral antigens are
collected and displayed by MHC-I class while MHC-II gathers and presents peptides from
intracellular vesicles. Should a T-lymphocyte recognize its specific antigen in the lymph
node, then the cell becomes activated. T cells differentiate into killer or helper cells,
depending on the interaction between the antigen, APC and the T cell. Some of the
activated T cells help B-cells to become activated when they have encountered their
specific antigen. B-cells recognize their specific antigens through direct binding to the B
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cell receptor. The activated lymphocytes leave the lymph node as effector cells that induce
the adaptive immune response.
5.1.2.1.1. T-effector cells
When a T-cell is activated, it starts to proliferate and differentiate into the effector cells
needed to destroy the antigen (Janeway et al. 2005). The effector cells may be grouped
into CD8+ cytotoxic T cells (CTL) also called killer cells or into CD4+ helper cells (Figure
1). The killer cells strive to achieve immediate clearance of pathogens to prevent them
from replicating inside the cell. T killer cells recognize the antigen on the APC bound to
MHC class I and kill the micro-organism through direct contact (Fig.1a).
T helper cells (CD4+)  recognize  antigens  bound to  MHC class  II  on  APCs.  T  helper
cells with different functions develop depending on the antigen as well as on the
immunologic predisposition of the responder (Lanzavecchia and Sallusto 2000). The T
helper cells are commonly grouped, in order to distinguish between the responses, into
subtypes called Th1 and Th2. Generally infectious bacteria induce a Th1 type of response
while allergens induce a Th2 type of response in susceptible individuals. The
differentiation into Th1 or Th2 type cells is a crucial step for effective immunity. The
mechanisms that control the differentiation are not fully understood but cytokines present
at the initial stage seem to play a major role but the process is also controlled by the
regulatory cells (O'Garra 1998). The differentiation steps are strictly controlled and the
activation of one type of responses inhibits the other type.
Th1 cells are activated in order to help macrophages prevent infectious microbes from
starting to grow and replicating inside the host cell (Fig. 1b). Th1 cells activate
macrophages and secret cytokines and chemokines that recruit more macrophages to the
site of infection (Murphy et al. 2000). IFN-  is the main trigger for Th1 cell
differentiation, and this cytokine inhibits the activation of Th2 responses and the
production of IgE. The production of Th1 type cytokines, and especially IFN- , is
stimulated by two early Th1 type cytokines, IL-12 and IL-18 (Dinarello 1999). IL-12 and
IL-18 are primarily secreted by the macrophages involved in the induction of pro-
inflammatory cytokines attracting inflammatory cells to the site of inflammation (Kumano
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et al. 1999). Th1 cells, macrophages and the cytokines secreted are the main participants
in cell mediated inflammatory reactions of Th1 type.
Th2 cells help the antigen to activate B-lymphocytes to produce antibodies and
therefore they play a crucial role in the development of humoral immunity. The allergen is
presented to the T- cell through the MHC-II on the APC and IL-4 production is induced
(Fig. 1c). IL-4 stimulates T helper cells to differentiate into type 2 cells (Th2) and these
cells in turn induce the production of subsequent activators of the response such as the
cytokines IL-5 and IL-13.  IL-4 and IL-13 are involved in the activation of B-lymphocytes
allowing  these  cells  to  produce  IgE antibodies.  The  recruitment  of  eosinophils  is  tightly
connected with the allergic Th2 type of response. IL-5 increases the formation, prolongs
the survival and induces the degranulation of eosinophils at the site of inflammation
(Hamelmann and Gelfand 2001). Activation of Th2 cells therefore triggers a response,
such that the interaction of Th2 cells and cytokines will favour humoral immunity i.e., the
production of IgE and an allergic type of response.
Figure 1 Different types of effector T cells specialized to deal with different antigens. Modified
from Janeway et al. 2005.
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5.1.2.2. Activation of B-lymphocytes
The main function of B cells is to produce antibodies against a foreign agent and to
maintain a pool of memory cells (Gold 2002). When a B lymphocyte has recognized its
antigen, with the help of T helper cells, it becomes arrested and activated. The cell
enlarges, transforming itself into a lymphoblast which then starts to divide. The dividing
lymphoblasts produce cells with identical specificity (a clone) and these then differentiate
into antibody secreting plasma cells (Ollila and Vihinen 2005). The antibodies are secreted
into the bloodstream and other extracellular fluids where they exert their action by binding
to the antigen or the pathogen. Binding then designates the antigen for elimination by
other cells. After the antigen has been eliminated, some of the differentiated plasma cells
remain, building up the so called memory. These memory lymphocytes react more rapidly
and effectively to a second infection.
5.1.2.2.1. Immunoglobulin classes
There are five main antibodies or immunoglobulin (Ig) isotypes IgM, IgD, IgG, IgA and
IgE which all have different effector functions and localizations in the body (Janeway et
al. 2005, Jelinek 2000). The initial antibodies secreted by B cells are of the M isotype.
IgM is found mainly in the blood where it is involved in the activation of the complement
system. IgG is the main isotype found in blood and extracellular fluids where it binds to
pathogens in order to facilitate their opsonization by phagocytic cells. Although IgE is
present only at low levels in blood, it plays an important biological role in immune
responses (Vercelli 2001). IgE binds very effectively to receptors on mast cells upon
antigen  recognition  and  this  triggers  the  release  of  the  mediators  responsible  for  the
(allergic) symptoms seen in IgE mediated allergy. Finally, IgA is found mainly in
secretions where it acts as a neutralizing antibody.
5.1.3. Immunomodulation
As mentioned above, the antigen on the APC determines the kind of effector T cells which
will be activated. Activation of a T helper type 1 response via secretion of IFN-  inhibits
the cell's differentiation to the type 2 response while cytokines such as IL-4 on the other
hand inhibit differentiation to type 1. The kind of cytokine milieu induced plays an
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important  role  in  determining  the  direction  of  the  response.  In  allergic  diseases,  it  is  the
Th2 response which predominates. In attempts to treat or modulate allergy, Th1 type
responses are activated in order to skew the response away from Th2. Bacteria or bacterial
components are strong Th1 immunostimulants and they have been successfully used to
modulate allergic responses in experimental models (Jain et al. 2003, Walker et al. 2003).
In that way, the allergic type of inflammation with eosinophilic infiltrates and the
production of IgE antibodies can be downregulated by appearance of Th1 type cytokines.
Regulatory T cells have lately been recognized to play an important role in the early
development and activation of an immune response. They have been shown to be
important in the maintenance of self-tolerance and they probably control the development
of autoimmune diseases and transplant rejections. They might therefore also be involved
in the control of allergic diseases (Hawrylowicz and O'Garra 2005, Robinson et al. 2004).
CD4+CD25+ regulatory T cells (Treg) have been found to be able to suppress T cell
proliferation. The interaction occurs through cell contact and the secretion of
immunosuppressive cytokines such as IL-10 and TGF- . The development of CD4+CD25+
regulatory T cells is tightly regulated by a transcription factor, Foxp3. There are two other
groups of regulatory T cells that are CD25-, these cells have been named TH3  and  TR1
(Umetsu et al. 2003). TH3 are regulatory helper 3 type cells that produce cytokines such as
IL-4, IL-10 and TGF-  while the regulatory cell T R1 secretes IL-10 and TGF- .
5.1.4. Hypersensitivity reactions
When the immune response is evoked against non-infectious antigens, hypersensitivity
reactions or allergy can develop and these can cause tissue damage. Coombs and Gell
classified the hypersensitivity reactions into four types called type I, II, III and IV
(Coombs and Gell 1963). The type I reaction is IgE mediated while type II and III are IgG
mediated. Type IV hypersensitivity reactions are T cell mediated and can be divided into
three subgroups based on the reactions they activate. In the following section only the
hypersensitivity reactions involved in the immune responses studied in this thesis will be
explained in more detail.
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5.1.4.1. IgE mediated allergy (type I)
IgE mediated allergy is characterized by the production of specific antibodies to an
allergen driven by Th2 effector cells. On a second encounter with the allergen, an allergic
immune response is induced. The immune response is characterized by an early and a late
response. In the early response, pre-formed inflammatory mediators, such as histamine,
are secreted when the antibodies produced against the allergen bind to the high affinity
IgE receptors present on mast cells (Broide 2001). The release of histamine and other
inflammatory mediators such as leukotrienes and prostaglandins causes a rapid increase in
vascular permeability and smooth muscle contraction. In the late response, cytokines and
chemokines participate in the activation and recruitment of more inflammatory cells such
as eosinophils and basophils. IL-5 activates and increases the formation of eosinophils,
and together with CCR3 binding chemokines such as CCL11/eotaxin-1 and
CCL5/RANTES, attracts these cells to the site of inflammation. If this delayed-phase
inflammation continues for a long time it can lead to a situation of chronic inflammation
with eosinophils and effector Th2 cells constantly being present. The reaction can cause
severe symptoms such as impaired airflow in the airways and sustained edema at the site
of inflammation.
The allergic reaction produces different clinical symptoms depending on the route of
allergen entry (Janeway et al. 2005). Inhalation of allergen is the most common route of
entry and is associated with symptoms in the nose (allergic rhinitis) or in the lower
airways (allergic asthma).
5.1.4.1.1. Allergic asthma
Allergic asthma is characterized by both an early (immediate) response, that can be
classified  as  type  I  hypersensitivity,  and  a  late  (delayed)  response  of  type  IV  with  Th2
effector cells orchestrating the inflammation (Figure 2). The allergic asthma reaction starts
when the allergen is inhaled and becomes bound to its specific antibodies situated on
submucosal mast cells in the lower airways. Mast cells are activated and trigger the release
of histamine, leukotrienes, prostaglandins and platelet activating factor (PAF) (Williams
and Galli 2000). The immediate asthmatic reaction is characterized by smooth muscle
contraction in the bronchial airways. The delayed response is initiated with the secretion
of IL-4 by mast cells to activate T-lymphocytes. Activated Th2 cells and basophils secrete
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IL-4 and IL-13, activating B-cells to produce more IgE antibodies. Th2 cells further
secrete IL-3, IL-5 and GM-CSF in order to recruit eosinophils (Kay 2001). Then, the
eosinophils release inflammatory mediators such as cationic proteins, leukotrienes and
PAF to the site of inflammation (Busse and Lemanske 2001). The late response of the
asthmatic reaction is characterized by swelling of the airway mucus membrane, increased
mucus secretion and increased (bronchial) airway hyperresponsiveness (AHR). If the
inflammation is allowed to proceed, Th2 lymphocytes and eosinophils will secrete more
IL-5 and GM-CSF, stimulating the bone marrow to produce more eosinophils. Epithelial
lesions start to develop due to the devastating effects of the cationic proteins constantly
being released by the eosinophils. The airflow is impaired and the inflammation may
develop into chronic asthma (Cohn et al. 2004).
Figure 2 Cells and mediators involved in the acute and chronic phase of allergic asthma.
Modified from (Kay 2001).
5.1.4.2. Type III hypersensitivity
Type III hypersensitivity reactions result from the inadequate removal of the immune
complexes formed in response to antigens. Repeated inhalation of antigenic material
induces the production of IgG antibodies which form immune complexes in the lung
intended to facilitate phagocytosis. The persistent presence of immune complexes
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activates mediators that induce local lung inflammation. Sustained exposure to high levels
of antigen may lead to alveolar cell wall membrane destruction. The high levels of mouldy
hay dust occasionally found in farming environments can induce a disease condition called
farmer's lung (Reboux et al. 2001, Terho 1982). Farmer's lung disease exhibits the
characteristics of type III hypersensitivity reactions such as IgG antibodies to the
offending antigen and the formation of immune complexes in the lung. IgG antibodies to
actinobacteria and fungi such as Aspergillus fumigatus are commonly found in the sera
from these patients (Erkinjuntti-Pekkanen et  al. 1999).  The lung histology reveals
granulomatous reactions and chest X-ray findings reflect the presence of immune
complexes in the lung (Sutinen et al. 1983).
5.1.4.3. Cell mediated immunity (type IV)
Type IV hypersensitivity reactions are delayed T cell mediated immune responses which
are divided into three types based on the reactions they induce (Roitt et al. 2001). In cell
mediated immunity, antigen specific T effector cells are activated upon recurrent
encounters  with  the  antigen.  The  tissue  damage  is  due  to  the  activation  of  Th1  cells
recruiting macrophages or Th2 cells that recruit mainly eosinophils. Direct tissue damage
is caused by cytotoxic T cells.
5.1.5. Allergens
An antigen able to activate the immune system to produce specific IgE antibodies and to
trigger an allergic reaction in susceptible individuals is called an allergen (Stewart and
Robinson 2003). Allergens enter the body via the airways, skin, gastrointestinal tract or
parenteral route and are usually presented to the host at very low doses which is thought to
favor the induction of the allergic Th2 type response (Janeway et al. 2005). Allergens are
mostly proteins or glycoproteins ranging in molecular weight from 3-80 kDa. They are
usually highly soluble and are resistant to heat, proteases and denaturing agents. Allergens
have several antigenic determinants on their surface called epitopes and it is to these
regions that the antibodies bind.  The antigenic determinants are commonly composed of
discontinuous amino acids brought close together in the three dimensional structure of the
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protein.  The epitope recognized in its 3D form is called a conformational epitope.
Antibodies may also recognize small continuous fragments on the polypeptide chain of the
protein called linear epitopes. The conformation is however most crucial for antibody
binding to the epitopes (Aalberse 2000).
5.1.5.1. IgE cross-reactivity
The IgE produced in response to an allergen might also bind to similar structures on other
antigens leading to cross-reactivity. In particular, taxonomically related antigens often
share antibody binding epitopes that cross-react for IgE binding (Aalberse et  al. 2001).
The high degree of homology in the primary structure of related proteins may produce
homologous 3D structures potentially leading to cross-reactivity. More than 70% sequence
identity between the proteins seems generally to be required for cross-reactivity to occur
(Aalberse 2000). Also non-related preserved proteins (pan-allergens) might possess cross-
reacting parts. Postsynthetic modifications such as glycosylation of proteins are commonly
involved in cross-reactivity between unrelated proteins due to cross-reactive carbohydrate
determinants (Ferreira et al. 2004). Cross-reacting antibodies may therefore induce
positive results to allergens to which the individual has not primarily been sensitized, due
to the similarities in the structure between the allergens.
5.2. Health effects linked to fungal exposure
We are constantly inhaling low levels of airborne fungal spores. Fungi are an integral part
of our natural environment and normally do not have harmful effects to human health. The
airborne fungal spores can originate from outdoor or indoor sources (Burge 2002,
Flannigan et al. 1991). Usually the levels of outdoor spores are slightly higher compared
to indoor levels (Shelton et al. 2002). The outdoor spore levels vary greatly depending on
climate and season.  In subarctic climates, outdoor spore levels are extremely low during
the winter season (Reponen et al. 1992).  In Finland, fungal spore levels reach their
maximum during late summer and autumn. During these periods, susceptible individuals
might experience sensitization to allergenic fungi originating mainly from outdoor
environments. A water damaged building with moist materials however, is a suitable
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growth area for fungi not normally found indoors (McGrath et al. 1999). Under these
circumstances, fungal growth and consequently fungal spore levels in the air may be
higher indoors than outdoors and health problems may arise. The health problems
commonly linked with exposure to microbes in damp buildings are allergic diseases and
nonspecific airway inflammation (IOM 2004, Portnoy et al. 2005).
5.2.1. Fungi
Fungi comprise a large kingdom of eukaryotic organisms divided into several taxonomical
groups and species. In the following section, only a brief introduction to the fungal groups
studied in this thesis will be described. Fungi are typically filamentous where the hyphae
grow at the tip and form branches called mycelium. Fungi may reproduce both sexually or
asexually by forming spores or conidia (Carlile et al. 2001, Deacon 1997). Fungi with
asexual morphology have artificially been grouped together into a group called Mitosporic
fungi, previously known as Deuteromycetes or Fungi Imperfecti. Mitosporic fungi are
further divided into classes and the fungi studied in this thesis belong to the class
hyphomycetes including asexual yeasts (Hawkswort et al. 1995). The hyphomycetes class
include many common soil and plant fungal species such as Cladosporium and Alternaria.
Food or grain spoilage fungi, including Penicillium and Aspergillus species which are
potential mycotoxin producers also belong to the hyphomycetes class. There are several
potential mycotoxin producers, e.g. Stachybotrys species commonly contaminate wet
wood and hay.  The budding yeasts in this class are sometimes separated into a subclass
called blastomycetes of which Candida and Pityrosporum species (spp.) are typical
examples. Generally however, when the name fungus is used here it includes both yeasts
and fungi of the hyphomycetes class (Figure 3). Filamentous (micro)fungi of the
hyphomycetes class that reproduce asexually by forming conidia or spores, are also
commonly called moulds (Gravesen et al. 1994).
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Figure 3 Moulds and yeasts belong to the hyphomycetes class.
5.2.2. Fungal growth in water damaged buildings
Water damage in buildings can lead to mould problems if the structures are not dried
properly. The prevalence of significant moisture damages in buildings was evaluated in
Finland in the 1990s and estimated to be as high as 50 % depending on how the damages
were defined  (Koskinen et al. 1999, Nevalainen et al. 1998). The proportion is estimated
to  be  approximately  the  same  in  other  countries  with  similar  climates  e.g.  the  northern
European countries and North America (Brunekreef et al. 1989, Platt et  al. 1989).
Buildings are still often imperfectly designed and poorly constructed which may  lead to
potential water leakage from outdoor or indoor sources (Reijula 2004). Modern buildings
are often tightly constructed in order to save energy and to keep them warm but this makes
the drying process difficult should water damage occur. Fungal growth may develop on
damp building materials and this can range from a few mouldy spots to large areas of
contamination.
5.2.2.1. Microbes indicating moisture problem indoors
A damp or water damaged building favours the growth of certain microbes that can be
considered as indicators of moisture problem (Gravesen et al. 1999). The typical microbes
found in material from water damaged buildings in Finland (Reijula 2004) are shown in
Table 1. Most of the microbes are moulds but also yeasts and bacteria (eg. Actinomycetes)
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are found (Andersson et al. 1997). Among the first microbes to colonize wet buildings are
Penicillium and Aspergillus species, while Cladosporium species are usually considered as
secondary invaders. Typical tertiary colonizers are Phoma herbarum and Stachybotrys
chartarum (Gravesen et al. 1994).
Table 1. Typical microbes found in material samples from water damaged buildings in

















Damp building moulds, and some of the yeast species, commonly belong to the group of
fungi that reproduce asexually. Moulds reproduce by forming spores whereas asexual
yeasts replicate by budding off new cells. Mould spores can become airborne and inhaled
into the airways (Burge 2002). It is not known at which spore level a contaminated
building becomes a risk to an individual's health. Exposure limits have been difficult to
quantify due to the fact that some microbes seem to be more harmful than others. National
guidelines on exposure limits have been published in relation to the microbes found in
moisture damaged buildings (STM 2003). Generally however, exposure to an average of
more than 1000 colony forming units (cfu)/m3 air has been considered as a potential health
risk (Flannigan et al. 1991). Exposure to fungi is commonly estimated by taking air
samples, collecting settled dust or by examining the building material.
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Exposure to inhaled fungi and fungal spore levels in the air can be assessed by air
sampling and microscopic identification of the species. Different air sampling techniques
have  been  used,  but  basically  a  certain  volume  of  air  is  sampled  and  the  spores  are
collected by size or sampled directly onto culture plates in order to count and identify the
spores and species (Portnoy et al. 2004). Semi-quantitative cultures may be used in order
to identify species and to determine the viable colony forming units (cfu) not only from air
samples but also from settled dust samples. Culturing techniques may however, favour the
growth of the fast growing species while the slow growing and non-viable specimens are
left undetected. New molecular biology techniques are being developed in order to
identify and quantify moulds in indoor air or dust samples using species specific primers
and probes for detection (Meklin et al. 2004, Zeng et al. 2004). The secondary metabolites
produced by the fungi are commonly detected from air or material samples using HPLC or
mass-spectrometry techniques (Engelhart et al. 2002, Tuomi et al. 1998).
5.2.2.2. Immunomodulatory fungal components
Fungal elements that might induce activation of the immune system are the fungal spore,
secondary metabolites, hyphae or part of the fungal cell wall. Part of the fungal proteins
and glycoproteins may also be allergenic and trigger the activation of the adaptive immune
system in susceptible individuals. However, commonly the first line of defence is directed
against those common parts of the fungi recognized as foreign to the host.
Cell wall components
The fungal cell wall contains a variety of molecules including proteins, polysaccharides
linked to proteins, lipids and carbohydrates. The major components of the fungal cell
walls are the polysaccharides (Carlile et al. 2001). Depending on the class of fungi,
different polysaccharides in varying proportions are embedded into the wall. Mould cell
walls contain mainly chitin and glucan while in yeast cell walls, glucans and mannans
predominate. The immune system responds to fungal cell wall components through innate
immune receptors such as Toll-like receptors (Netea et al. 2004). In particular, (1 3) -
D-glucan and mannan have been shown to be potential fungal PAMPs recognized by the
receptors triggering the innate immune system (Roeder et  al. 2004). Also the more
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common cell wall constituent of moulds, chitin, has been shown to have
immunomodulatory properties in airway inflammation (Strong et al. 2002).
Secondary metabolites
Many of the fungal species found in damp buildings can produce secondary metabolites
under certain optimal growth conditions such as high humidity, a suitable medium and
temperature (Nielsen 2003). The secondary metabolites are produced by the fungi in an
attempt to fight for living space and have been shown to be highly species specific. Many
fungal species found in moisture damaged buildings are potential toxin producers and
their toxins, mycotoxins, have been isolated and identified from the building materials
(Tuomi et al. 2000). Mycotoxins are capable of inhibiting protein synthesis and may exert
immunosuppressive, hemolytic, cytotoxic or neurotoxic effects depending on the toxin
(Sudakin 2003). Fungi can also produce other secondary metabolites e.g., enzymes with
protease or proteolysing activities, which might also be potent immunostimulators. Fungal
proteases, especially those produced by pathogenic fungi, have been observed to trigger
the production of pro-inflammatory cytokines in vitro (Kauffman et al. 2000).
5.2.2.3. Health effects
Exposure to damp buildings has commonly been linked to many different health effects
often described as coldlike symptoms. Epidemiological clinical studies have revealed that
people exposed to damp buildings suffer more often from upper and lower respiratory
tract infections and allergic diseases compared to people living in healthy buildings
(Andrae et al. 1988, Andriessen et al. 1998, Bornehag et  al. 2001, Norback et  al. 1999,
Verhoeff  and  Burge  1997).   Typical  allergic  diseases  which  may  be  associated  with
exposure are rhinitis and asthma. Eye irritation, cough, headache, dizziness, nausea and
joint pain are some of the more nonspecific symptoms reported. These symptoms are
thought partly to be caused by exposure to fungi and the secondary metabolites produced
by the fungi growing on damp building materials (Garrett et  al. 1998, Peat et  al. 1998,
Sudakin 1998).  In rare cases, fungi may be infectious. With respect to the typical damp
building moulds, Penicillium and Aspergillus are allergenic while certain species such as
27
Aspergillus versicolor and Stachybotrys chartarum are potential toxin producers and
therefore considered as a health risk (Bush and Portnoy 2001).
5.2.3. Allergy to fungi
Individuals, especially atopic individuals with an inherited tendency to produce IgE
antibodies, can become sensitized to allergenic moulds (Kurup et al. 2000). Sensitization
is characterized by IgE antibodies and positive skin test reactions to the allergen.
Sensitization can occur through inhalation in the airways, mucous membranes or in the
skin. Sensitized individuals may develop allergic symptoms upon subsequent exposure,
manifesting itself as allergic rhinitis or asthma if they have been sensitized and challenged
via  the  airways.  Sensitization  to  moulds  through the  skin  may occur  in  situations  where
mouldy materials are handled; in this case the moulds can induce allergic symptoms such
as eczematous skin reactions.
5.2.3.1. Allergenic fungi
Fungi contain many allergenic components but the spores have been found to contain the
most allergenic (Horner et al. 1995). Most of the allergenic fungi belong to the
taxonomical group Deuteromycetes which replicate asexually (imperfect fungi) by
forming spores or conidia. Fungal spores have been shown to be allergenic to varying
degrees depending on the species. Species that are considered highly allergenic are
Alternaria alternata, Cladosporium herbarum, Aspergillus fumigatus as well as
Penicillium species (Bush and Portnoy 2001).
Cladosporium herbarum and Alternaria alternata
Cladosporium herbarum and Alternaria alternata are two of the most common allergenic
fungi used in allergy tests when allergy to fungi is suspected. A. alternata is a worldwide
sensitizer and despite its rather large spore size (20-80 m) has been shown, together with
Aspergillus  species,  to  be  one  of  the  most  potent  sensitizers  in  terms  of  spore  numbers
(Beaumont et al. 1985, Gautrin et al. 1994). C. herbarum is found in high spore numbers
especially in cooler climates but, in comparison with its high spore counts, it is not as
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potent a sensitizer as Alternaria. C. herbarum and A. alternata are typical fungi found in
the outdoor air. They are common saphrophytes found on decaying plants, foodstuffs, in
the soil and on decaying wood (Gravesen et al. 1994). Should there be water damage
indoors they may also start to colonize the wet building material.
5.2.3.2. Cross-reactivity between fungal allergens
There is known to be considerable cross-reactivity between fungi (Kurup and Banerjee
2000). Commonly cross-reactivity is encountered between species of the same genus but
can also be seen between different genera and classes of fungi. Fungi, in general, contain
conserved allergens such as enolases (Breitenbach et al. 1997). These components are
found in many species and plants which are not related to each other. In addition, moulds
contain cross-reacting conserved allergens such as aldehyde dehydrogenase, aldolase and
acidic ribosomal proteins (Kurup and Banerjee 2000, Shen et al. 1998, Weichel et al.
2003). Phylogenetically related moulds such as Aspergillus and Penicillium species seem
to share several cross-reacting allergens (Schmechel et al. 2005). Yeasts share cross-
reacting protein allergens such as enolase and peroxisomal membrane proteins between
species but cross-reactivity to Aspergillus fumigatus mould allergens has also been
observed. Typically yeasts seem to share similar cell wall carbohydrate components such
as mannans between different genera and species (Doekes et al. 1993, Lintu et al. 1999).
5.2.3.3. Prevalence of sensitization
Sensitization to fungi may occur outdoors as well as indoors and is therefore not always
linked to exposure to indoor moulds. Sensitization to airborne fungal spores occurs mainly
via the airways. The prevalence of respiratory allergy to fungi has been estimated as being
about 6% in the general population (Horner et al. 1995, Kurup et  al. 2000) with only
minor variations between countries (Bush and Portnoy 2001). The sensitizing fungal
species vary slightly depending on the living conditions and the climate. Different fungal
allergen extracts and diagnostic techniques also account for some of the variation in
prevalence seen in epidemiological studies. In addition, the selection criteria for the study
population strongly affect the prevalence. In an atopic population, the prevalence for
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sensitization has been shown to be higher (20-30%) due to their inherited susceptibility to
develop IgE mediated diseases. The age of the study group also affects the prevalence,
showing higher values in children (Kauffman et  al. 1995, Koivikko et  al. 1991). The
prevalence of sensitization to C. herbarum and A. alternata was shown to be highest at the
age of eight years, declining with increasing age (Nolles et al. 2001).
5.2.3.4. Association with mould induced asthma
Prolonged exposure to increased levels of allergenic fungal spores is able to induce
allergic asthma or to exacerbate asthma symptoms in susceptible individuals  (IOM 2004).
Exposure to some of the allergenic fungal species, such as Alternaria alternata and
Aspergillus fumigatus, has been linked with an increased risk to develop allergic asthma
(Downs et  al. 2001). Epidemiological studies have shown that sensitization, especially
sensitization to Alternaria, is common among subjects with asthma (D'Amato et al. 1997).
The association was shown to be more pronounced in children and to decrease with age in
accordance with sensitization (Nolles et al. 2001).
5.2.4. Non-IgE mediated airway responses linked to exposure
Exposure to fungi can also induce irritation and inflammation of the mucus membranes in
the eyes and in the respiratory tract. The airway response may resemble allergic responses
but are not IgE mediated. Other antibodies such as IgG may play a part in the initiation of
these airway responses (Gravesen et al. 1994).  The inflammatory airway responses may
result in irritant asthma or other asthma like symptoms (IOM 2004).
5.2.4.1. Innate airway response
Inhalation  of  airborne  spores  activates  the  defence  system  of  the  host  to  attempt  to
eliminate the foreign agent. Initially, when fungal spores enter the upper airways, the
largest spores are filtered and washed away by the nasal mucosa. The smaller spores, less
than 10 m in diameters, may be inhaled into the lungs (Geiser 2000). Only fungal spores
less than 3 m in diameter are small enough to reach the terminal bronchioles and alveoli
but once there alveolar macrophages recognize them as foreign and start to eliminate the
30
spores (Knox and Homer 2003). The inflammatory immune response is activated with the
release of pro-inflammatory cytokines. This immune response is in most cases sufficient
to eliminate the antigen. If however, the antigen is still presented on the inflamed mucosa
after a period of a few days or weeks, then the adaptive response may be activated to
eliminate the antigen.
5.2.4.2. Hypersensitivity syndrome due to fungi
Prolonged exposure to extremely high concentrations of fungal spores may lead to a
disease  condition  which  exhibits  the  characteristics  of  both  type  III  and  IV
hypersensitivity reactions. IgG to moulds is found in sera of exposed persons but the role
of IgG in this hypersensitivity reaction is not clear (type III) (Marinkovich 2004). The cell
mediated immune response of Th1 type with activated macrophages (Type IV) seems to
play the main role in these reactions. If the macrophages are unable to eliminate the fungal
spores,  then  they  fuse  into  epitheloid  cells  and  giant  cells  leading  to  the  granuloma
formation typical of extrinsic allergic alveolitis or hypersensitivity pneumonitis (HP). The
high fungal spore concentrations that might induce this condition can occasionally be
found in barns or workplaces where mouldy hay (A. fumigatus) or wood pulp (A.
alternata) is being processed (Gravesen et al. 1994).
5.2.4.3. Infection
In rare cases, such as in immunocompromised individuals, fungi may be infectious.
Aspergillus fumigatus is one of the moulds that may colonize the lungs of
immunosuppressed individuals and induce a disease condition called aspergillosis. Fungal
colonization of lungs places a heavy burden on the immune system and frequently, the
individual has to be treated with antifungal drugs in order to eliminate the fungi (Wark et
al. 2003). Also opportunistic yeasts, such as Candida albicans, which normally colonizes
mucosal surfaces, may be converted into a pathogen in immunosuppressed individuals and
induce a systemic infection (Nucci and Marr 2005).
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5.2.5. Diagnosis of health effects associated with fungal exposure
Many investigations have been undertaken to examine the health problems experienced by
individuals occupying damp buildings but still controversy exists concerning the cause
and effect of exposure to moulds. Sensitization to moulds can be demonstrated with
allergy tests but there are few tests or markers which can be used for the non-specific
symptoms associated with exposure. Commonly the first step taken in a damp building
case with linked health problems is a microbial evaluation of the building. The health
problems may be evaluated by using questionnaires or clinical examinations of the
patients. Allergy in vivo tests such as skin prick tests (SPT) and in vitro antibody
measurements from sera are widely used when diagnosing sensitization to fungi (Trout et
al. 2004). In the context of diagnosing occupational diseases, potential asthma associated
with exposure is examined with lung function tests. Allergen provocation test are often
needed to confirm the association between the sensitizing agent and the disease.
The non-allergic health effects linked to exposure to damp building moulds have
however been difficult to demonstrate experimentally or in patient samples. The occupants
of a damp building "feel sick" in many different ways but the symptoms are diverse and
difficult to relate directly with their exposure to moulds at the level of the individual.
Epidemiological and cross-sectional studies have clearly shown increased incidences of
upper and lower airway symptoms in occupants of damp buildings (Brunekreef 1992,
Dales et al. 1991, Koskinen et al. 1999, Savilahti et al. 2000, Taskinen et al. 1999). Many
attempts have been made to identify inflammatory markers in the respiratory organs such
as the nose or the lungs. Changes in cell composition or in cytokine levels in broncho-
alveolar lavage samples have been used to study lung diseases in general but there have
been few studies conducted on patients exposed to fungi. Nasal lavage and induced
sputum are also used in the diagnosis of airway disease and some of the studies have
focused on exposure to damp buildings (Walinder et al. 2001). Their results suggest that
higher levels of inflammatory mediators are present in nasal fluid from patients in  a
moisture damaged building compared to controls (Hirvonen et al. 1999).
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5.2.6. Stachybotrys chartarum
In 1986 Croft et al. reported adverse health effects linked to a damp building where
Stachybotrys chartarum growth was found in large areas of the building (Croft et al.
1986). Since then, many other cases of health problems have been associated to exposure
to S. chartarum (Dill et al. 1997, Hodgson et al. 1998, Johanning et al. 1996). The
commonest health complaints have been headache, sore throat, fatigue, dermatitis, general
coldlike symptoms and malaise. Special attention was drawn to a cluster of cases in
Cleveland Ohio in the 1990's where several infants became seriously ill suffering from
idiopathic pulmonary hemosiderosis (Dearborn et  al. 1999). S. chartarum was  found  in
large numbers in the children's bedrooms. However it has never been confirmed whether
S. chartarum was actually responsible for the children's symptoms (CDC 2000). One of
the reasons for blaming S. chartarum for health effects is that under suitable circumstances
it possesses the ability to produce highly toxic macrocyclic trichothecenes (Hintikka 1978,
Hintikka 2004).
Figure 4 Stachybotrys spores (conidia). Spore size range from 5-12 m.  Scanning electron
micrograph with permission from an article by Berlin D. Nelson in November 2001
APSnet, courtesy of the American Phytopathological Society.
5.2.6.1 Secondary metabolites produced by S. chartarum
Stachybotrys may produce different secondary metabolites with many different potential
health effects depending on the strain (Nielsen 2003). The Stachybotrys strains found in
Cleveland have been characterized in detail and the toxins analyzed (Jarvis 2002). Many
of  the  strains  produced  not  only  the  macrocyclic  trichothechenes,  satratoxin  G  and  H,
roridins, stachybotrylactones and lactams, but also proteases, atranones and hemolysin.
Trichothechenes have been shown to inhibit protein synthesis and to be cytotoxic to
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eukaryotic cells while the lactones and lactames are immunosuppressive. Stachybotrys
derived proteases have been reported to cause tissue damage whereas the atranones have
only been recently identified and their function is still unknown (Kordula et al. 2002, Yike
et al. 2002). The hemolysin (stachylysin) has been shown to cause hemolysis of red blood
cells (Vesper et al. 2001).
5.2.7. Experimental studies
Experimental models are frequently used to study exposure to moulds. The experimental
models can be used to study physiological, immunological and histological changes in the
lungs after exposure to mould allergens and mould spores, also toxic spores, which would
not be possible in human studies. In order to mimic the natural exposure route for
inhalants, the airways are commonly exposed directly. This can be achieved by nebulizing
the antigen into a closed chamber where experimental animals such as mice inhale the
aerosolized antigen (Korpi et al. 2002). The antigen can also be installed directly into the
airways using intratracheal (i.t.) instillation (Jussila et al. 2002). One method representing
the situation in between inhalation and i.t. can be achieved by intranasal instillation
(Cooley et al. 2000). In intranasal instillation, a drop of the antigen suspension is installed
on the nose of an anaesthetised animal which then inhales it into the lungs. In allergen
sensitization studies, in order to induce allergic asthma, the allergen is commonly injected
intraperitoneally at first to induce sensitization and later directed to the airways by
inhalation.
Exposure to Stachybotrys
Stachybotrys chartarum has often been the microbe of choice when exposure to damp
building moulds has been investigated in experimental models (Yike and Dearborn 2004).
Toxin producing and non-producing strains have been used as well as pure toxins. S.
chartarum spores and toxins have mostly been installed intratracheally into mice followed
by evaluation of histological and morphometric changes in lung tissue (Rand et al. 2003).
Rats have also been used and commonly changes in the cell population in the BAL fluid
have been studied after intratracheal installations (Rao et al. 2000). An attempt to mimic a
real life exposure situation has also been made where mice inhaled spores of S. chartarum
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directly from agar plates (Wilkins et al. 1998). The technique of installing S. chartarum
spores intranasally repeatedly was introduced by our group in order to mimic long time
exposure (Nikulin et al. 1996, Nikulin et  al. 1997). The main effects of exposure were
studied from the histological lung sections.
Allergic fungal asthma
Experimental models studying sensitization and the development of allergic fungal asthma
have commonly used typical allergenic moulds such as Penicillium or Aspergillus species.
In fact, Apergillus fumigatus has been the most widely evaluated fungus. Exposure to A.
fumigatus has been linked to allergic asthma and sensitization and exposure to A.
fumigatus allergenic extracts has been extensively studied (Haczku et al. 2001, Kurup et
al. 2001). These models of acute and chronic asthma induced by A. fumigatus have added
important data concerning the role of chemokines and chemokine receptors in the
pathogenesis of the disease (Blease et al. 2001, Schuh et al. 2002). Penicillium species are
commonly found in damp buildings and allergic inflammation was recently induced in a
murine model using a purified protease allergen from Penicillium chrysogenum  (Schwab
et al. 2004).
Allergic asthma model
The acute allergic asthma model has proved to be useful for studying the pathogenesis and
possible treatment of allergic asthma (Epstein 2004, Gelfand 2002). The mouse model of
allergic asthma exhibits the main characteristics associated with human asthma. The
allergized mouse present with airway hyperreactivity (AHR), an eosinophilic lung
infiltrate, specific IgE antibodies to the sensitizing allergen and a Th2 type inflammatory
response in the lungs (Tomkinson et al. 2001). The protocol involves a sensitization
period (allergen injected intraperitoneally) after which the reaction is directed to lungs by
challenging the airways with the allergen. The most commonly used allergen in this model
 is ovalbumin (OVA).
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6. AIMS OF THE STUDY
Exposure to allergenic or toxic fungal spores is considered to be one of the major inducers
of the health problems linked to water damaged buildings. Sensitization to moulds may
explain part of the symptoms but other components such as the toxins in mould spores
may also play an important role. In addition, the immunological status of the exposed
individual may modulate the extent of the response.
The specific aims were:
1. To evaluate the prevalence of sensitization to two common moulds in patients
attending a hospital for suspected allergy.
2. To characterize the IgE binding to fungal allergen extracts in sera from mould
sensitized patients in order to study the specificity of the binding to moulds.
3. To study the airway responses to a toxin producing damp building mould,
Stachybotrys chartarum, in an experimental model.
4. To study the interaction between experimental allergy and exposure to
Stachybotrys chartarum in the airways in order to determine whether the
immunological status affects the response.
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7. SUMMARY OF METHODS
A more detailed description of the material and methods used in this study can be
found in the original publications (I-IV).
Figure 5 Summary of  study design.
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7.1. Sensitization to moulds, PATIENT STUDIES
7.1.1. Study subjects
Patient screening (I)
A group of 6376 patients examined at the Skin and Allergy Hospital in Helsinki during
January 1996 to May 1997 was skin prick tested for 11 common inhalant allergens
including Cladosporium herbarum. The patients had attended this hospital due to
suspected allergy. Of these, 1504 patients with a history of indoor air problems were
further tested with a special fungal allergen panel.
Mould sensitized patients (I, II)
Serum samples were obtained from 40 patients sensitized to moulds. All patients
demonstrated a SPT wheel diameter  4 mm to C. herbarum and part  of them also to A.
alternata, 23 were females and 17 males (mean age 34 years, range 14 – 60).
Control patients (I, II)
Serum samples from 20 non-atopic (16 females and 4 males, aged 25-57) and 20 atopic
(14 females and 6 males, aged 16-57, with no mould positive SPT results) persons were
used as controls. All patients gave their informed consent to participate in the study. The
study was approved by the ethical committee of the Skin and Allergy Hospital, Helsinki
University Central Hospital.
7.1.2. Allergen extracts
Commercial allergen extracts (I, II)
Skin prick tests (SPT) and water soluble fungal extracts were from ALK, Abello
(Denmark/Spain). The 11 common inhalant allergens were cat, dog, horse and cow
epithelium; birch, timothy, mugwort and meadow grass pollen; D. pteronyssinus; natural
rubber latex (SQ 10 HEP, ALK) including C. herbarum (1/20 w/v).  The allergen extracts
in the fungal panel were A. alternata, Aspergillus fumigatus, Aureobasidium pullulans,
Fusarium roseum, Mucor racemosus, Penicillium notatum, Phoma herbarum, Rhizobus
niger, Rhodotorula rubra (1/20 w/v) and  Acremonium kiliense (5 mg/ml).
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Preparation of in-house fungal extracts (I)
Alternaria alternata (strain LS14/2) and Cladosporium herbarum (strain HRA MI)
isolated from water-damaged buildings (referred as FIOH antigen in article I) were grown
in mycological peptone liquid medium for three weeks at room temperature. The fungal
cultures were homogenized (Ultra-Turrax, IKA, Labortechnik, Staufen, Germany) and
centrifuged for 30 min at 4oC 3600 x g (Heraeus Minifuge RF, Hanau, Germany). The
supernatants were preparatively purified using HPLC (Source RPC15, Pharmacia,
Uppsala, Sweden) with a linear acetonitrile gradient (15% to 100%). The eluted protein
fractions were pooled, concentrated by Speed-Vac evaporation and the protein
concentration of the extract was determined.
Enzymatic deglycosylation of fungal extracts (II)
The SPT extracts were enzymatically deglycosylated (Enzymatic Protein Deglycosylation
Kit, Sigma-Aldrich Inc., St. Louis, MO, USA). The enzymes included in the kit can cleave
and remove all N-linked and simple as well as complex O-linked carbohydrates from
glycoproteins. The extent of deglycosylation of the extract was assessed on SDS-PAGE
gels and the protein concentration measured.
Separation of glycoproteins from the extract with ConA Sepharose affinity
chromatography (II)
The glycoproteins were separated from the allergen extract by running the extract through
a mannan binding ConA Sepharose affinity chromatography system. Briefly the extract
was diluted into the running buffer (0.01 M Tris HCl, 0.5 M NaCl, 0.01% NaN3, pH 7.4)
according to the manufacturer's instruction and applied to a column packed with ConA
Sepharose (Pharmacia Biotech).  The non-binding portion was collected as the extract free
of glycoproteins. The column was washed and the bound part was eluted from the column
with borate solution. The fractions were desalted (Sephadex G25), concentrated by Speed-
Vac evaporation and the protein concentration was measured.
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7.1.3. Clinical in vivo allergy tests (I)
SPT was performed on the volar forearm according to standard procedures at the Skin and
Allergy Hospital in Helsinki. SPT was repeated in the 40 patients showing positive SPT
reactivity to A. alternata or C. herbarum using both commercial extracts (ALK) and the
specially prepared in-house A. alternata extract. The in-house SPT extract of A. alternata
was diluted to a concentration of 100 mg/ml in phosphate-buffered saline, pH 7.4.
Conjunctival challenge was performed by an ophthalmologist according to standard
procedures at the Skin and Allergy Hospital in Helsinki. Water-soluble extracts of A.
alternata and C. herbarum (1/100 w/v, ALK) were used.
7.1.4. Immunochemical in vitro allergy tests
IgE-antibodies to A. alternata and C. herbarum and total IgE concentrations were
measured by the Pharmacia CAP FEIA method (Pharmacia AB, Uppsala, Sweden) at the
Skin  and  Allergy  Hospital  in  Helsinki.  In  addition,  IgE antibodies  were  measured  by  an
ELISA method.
ELISA and inhibition ELISA (I and II)
IgE reactivity to fungal extracts was assessed by ELISA. Briefly microtiter plates
(Immunoplate, Nunc, Roskilde Denmark) were coated with fungal extracts at a
concentration of 15 g/ml in sodium carbonate buffer (pH 9.6) overnight at 4 C. The
antigen  on  the  plate  was  pre-blocked  with  a  residual  coat  (human  serum  albumin  in
sodium carbonate buffer), washed with PBS-Tween and incubated with the serum (diluted
1:10).  The IgE was coupled to biotinylated anti-human IgE (Vector Laboratories) after
which alkaline phosphatase (AP)-Streptavidin (Zymed, San Francisco) was added. The AP
substrate was added and the absorbance was measured at 405 nm using an ELISA plate
absorbancereader (Multiskan MS, Labsystems, Turku, Finland).
In inhibition-ELISA, the serum samples were pre-incubated with the inhibitor for one
hour before they were added to the plates. All the other steps were as for ELISA.
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Immunoblot (II)
IgE binding to the allergens in the fungal extracts were visualized by immuno-blotting.
Briefly, the proteins in the mould extract were run on a SDS-PAGE gel (MiniProtean
system, Bio-Rad) and then transferred to a polyvinyldifluoride (PVDF, Millipore)
membrane in a Western Blot system (MiniBlot, Bio-Rad). The membrane was pre-blocked
with 5 % milk powder in Tris buffered saline (TBS) and the serums (diluted 1:5 in TBS-
milk) were added onto the membrane and incubated overnight at 4 C using a mini-blotter
apparatus (Intermedica). The blot was washed with TBS-Tween and incubated with
biotinylated anti-human IgE, AP-Streptavidin and finally with the AP-substrate (Color
Development kit, Bio-Rad).
In inhibition-immunoblot studies, the serum samples were pre-incubated with the




BALB/c female mice, 6-8 weeks of age, were used in experimental works III and IV. In
addition, transgenic mice carrying the ovalbumin (OVA)323-339-specific  DO11.10 T cell
receptor (OVA-TCR) were used in work IV. The mice were housed in specific pathogen
free  conditions  and  maintained  on  an  ovalbumin  free  diet.  All  the  experiments  were
approved by the Social and Health Care Department at the State Provincial Office of
Southern Finland.
7.2.2. Microbe preparations
Stachybotrys chartarum was chosen as a model organism in order to study the airway
responses to a mycotoxin producing damp building mould. The S. chartarum strains s. 29
and s. 72 (NRRL 6084) were grown on rice flour agar for two weeks at room temperature
and for an additional two weeks at 4 C to induce toxin production. The spores were
suspended from the plates into phosphate buffered saline (PBS, pH 7.2) and counted.
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An antigen suspension was prepared from the spore suspension. The spores were
broken on ice using an ultrasonic processor (Branson Sonic Power Comp.). The unbroken
spores were centrifuged down (3500 rpm, 4 C, Minifuge RF Heraeus) and the supernatant
was filtered (0.45 m pore size) and used as the antigen suspension. The protein
concentration was determined from the suspension and used in the antibody analysis.
A yeast, Saccharomyces cerevisiae, was  used  as  a  control  in  order  to  be  able  to
compare the responses of S. chartarum to a benign microbe. S. cerevisiae, also known as
the bakers yeast is generally considered harmless (Anadon et al. 2006). The yeast
(Rajamäki, Alko) was grown on malt extract agar for 48 hours in 37 C,  the  cells  were
suspended into PBS and counted. The spore- and cell-suspensions were -irradiated at
intensity 10 kGy before use.
Preparation and analysis of mycotoxin samples (III)
Mycotoxins were extracted from the S. chartarum spore suspensions with aqueous 95%
methanol, purified by a hexane wash and solid-phase extraction, separated by reverse-
phase HPLC, identified by tandem mass spectrometry, and quantified using electrospray
ionization on a quadrupole ion trap mass analyzer, as described previously (Tuomi et al.
1998).
Mass spectrometric analysis verified that the non-satratoxin producing strain (s. 29)
did not produce any detectable amounts of either satratoxin G or H and only minor
amounts of stachybotrylactam and stachybotrylactone (< 1ng/105 spores). On the contrary,
the satratoxin producing strain (s. 72) produced satratoxin G and H, stachybotrylactone
and stachybotrylactam in amounts of 4 ng, 10 ng, 8 g and 2 g respectively per 105
spores.
7.2.3. Experimental procedures
Intranasal administration of microbe preparations (III, IV)
The fungal spore and yeast cell suspensions were administered intranasally (i.n.) under
light anaesthesia (using methoxyflurane in work III and isoflurane in work IV) two times a
week for three weeks. The fungal spores (strain s. 29 and s. 72) and yeast cells were
administered into the mouse nostrils at two different concentrations (1x103 and 1x105 in
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25 l PBS in work III while 2x105 spores in a volume of 50 l were used in work IV), the
control group received PBS only.
Exposure to S. chartarum spores in experimental asthma (IV)
Mice were sensitized by intraperitoneal (i.p) injection of 20 g ovalbumin (Grade V;
Sigma) or sham sensitized with PBS emulsified in alum on days 0 and 10. On day 2, the
intranasal instillations of mould spores, yeast cells or PBS were started. The suspensions
were administered intranasally (i.n.) under light anesthesia (IsoFlo, Schering-Plough
Animal  Health  Corp.,  Union,  New  Jersey,  USA)  two  times  a  week  in  parallel  with  the
ovalbumin  sensitization  and  the  challenge  protocol.  The  spore  or  cell  concentration  per
instillation was 2x105 in 50 l PBS. Finally, on days 20-22, the mice were challenged with
1% aerosolized OVA for 20 minutes.
Figure 6 Schematic illustration of the sensitization and exposure protocol.
Sensitization of OVA transgenic mice and in vitro stimulation of splenocytes (IV)
Transgenic mice which express the OVA-specific TCR, were sensitized by i.p. injection of
OVA emulsified in alum on days 0, 14 and 21. On day 22, single-cell suspensions of
spleen cells from naive and sensitized mice were prepared in complete RPMI 1640
(Gibco, Invitrogen Corp. UK). Cells were cultured in the presence of OVA (50 g/ml) or
S. chartarum spores (105) and collected after 6 hours.
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7.2.4. Functional tests, sample preparation and measurements
Determination of airway responsiveness (III and IV)
Airway responsiveness was assessed using a single chamber whole body plethysmograph
system obtained from Buxco (Troy, NY, USA). The airway responsiveness was measured
48 hours after the last i.n. microbe instillation (III) but 24 hours after the last OVA
inhalation challenge (IV). Briefly, the unrestrained animal was placed into a chamber and
exposed for 5 min to nebulized PBS and subsequently to increasing concentrations of
methacholine (MCh) (Sigma) using an AeroSonic 5000 D ultrasonic nebulizer
(DeVilbiss). After each nebulization, recordings were taken for 5 min. The enhanced
pause (Penh) values were measured during each 5 min sequence and were expressed for
each MCh concentration as the percentage of baseline Penh values following PBS
exposure (% baseline Penh).
Sample collection (III and IV)
The mice were sacrificed by CO2 asphyxiation. The blood was drained from the hepatic
vein. The chest cavity was opened and the lungs were lavaged with PBS via the tracheal
tube.  The  left  lung  was  removed for  RNA isolation.  Part  of  the  right  lung  was  perfused
with 10% formalin while the other part was embedded into Tissue-Tek O.C.T Compound
and quick frozen.
BAL cytology and lung histology (III, IV)
The bronchoalveolar lavage (BAL) sample was cytocentrifuged (Cytospin, Shandon Ltd.,
UK)  on  a  slide  and  the  cells  were  stained  with  the  MayGrünwald-Giemsa  (MGG)  stain
and differentials counted under light microscopy. The lung specimens in formalin were
embedded into paraffin, cut, affixed to microscope slides and deparaffinized. The slides
were stained with hematoxylin and eosin (HE) stain and examined under light microscopy.
The OCT lung samples were cut, stained immunohistochemically with monoclonal
antibodies against CD3, CD4 and CD8 (BD Biosciences Pharmingen, San Jose, CA) and
counted under light microscopy in study IV.
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Real-time quantitative RT-PCR (III and IV)
Total RNA was extracted from the lungs and splenocytes using Trizol Reagent
(Invitrogen, NY, USA) and was reverse transcribed into cDNA with MultiScribe Reverse
Transcriptase (Applied Biosytems, Foster City, CA, USA) and random hexamers as
primers according to the manufacturer's instructions. The real-time quantitative
polymerase chain reaction (PCR) was performed with an AbiPrism 7700 Sequence
Detector System (SDS) (Applied Biosystems), according to the manufacturer's
instructions. PCR primers and probes were predeveloped assay reagents or generated by
PrimerExpress version 1.5 software and ordered from Applied Biosystems. The PCR
products were detected directly by monitoring the increase in fluorescence of the reporter
dye, FAM or VIC™ labeled. The FAM signals of the target gene were standardized to the
VIC signals of the endogenous reference gene, 18S rRNA, to control for sample loading
and to allow normalization between samples. The final results were expressed as relative
quantities as described in article III.
BAL cytokines and chemokines (III and IV)
The levels of cytokines (TNF-  and IL-13) and chemokines (CCL3 and CCL11) in the
BAL fluid were measured with commercial kits (R&D Systems, Minneapolis, MN, USA)
according to the manufacturer's instructions.
Serum antibodies (III and IV)
Total IgE in serum was measured by ELISA. Briefly, a 96 well plate (Immunoplate,
NUNC, Roskilde, Denmark) was coated with purified anti-IgE (Pharmingen, San Diego,
CA, USA). The diluted serum samples were added to the plate and incubated overnight.
Biotinylated anti mouse IgE and streptavidin horseradish peroxidase together with the
substrate (ABTS Microwell Peroxidase Substrate System, KPL, Gaithersburg, Maryland,
USA)  was  used  to  detect  the  bound  antibody  levels  measured  with  an  ELISA  plate
absorbancereader. Total IgE levels were calculated by comparing with known mouse IgE
standards.
S. chartarum and OVA specific serum IgE, IgG1 and IgG2a were measured by
ELISA. The plate was coated with either S. chartarum antigens (20 g/ml) or OVA (2
g/ml). The diluted serum samples were added to the plate and incubated overnight.
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Biotinylated IgE, IgG1 or IgG2a (Pharmingen, San Diego, CA, USA) was added as the
detecting antibody.  The reaction was amplified with streptavidin horseradish peroxidase
together with the ABTS substrate and detected with the ELISA plate absorbancereader.
The OVA specific antibody levels were compared between the groups.
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8. RESULTS
8.1. Sensitization to moulds in patients
8.1.1. Prevalence (I)
The prevalence of sensitization to moulds was evaluated in a material of 6376 patients
visiting the Skin and Allergy Hospital in Helsinki for suspected allergy. Positive SPT
results to Cladosporium herbarum were found in 2.7% of these patients. C. herbarum is
one member of a panel of commonly used inhalant allergens.  In cases of indoor air
problems, a special series of fungal allergens is included. Indoor air problems were
suspected in 1504 patients who therefore underwent skin prick testing also to other fungal
allergens including Alternaria alternata.  Positive SPT results to A. alternata were found
in 2.8% of these patients. In addition, positive SPT results were found in 2.1% of the
patients to Fusarium roseum, 1.7% to Phoma herbarum, 1.6% to Mucor racemosus and
0.9% to Aspergillus fumigatus.
8.1.2. Patients, clinical features (I, II)
Forty patients sensitized to either C. herbarum or A. alternata were invited for further
testing and their clinical features were studied in more detail. Of these patients, 58% were
found to have atopic eczema, 44% had asthma and 31% had rhinitis. In addition, the
majority  of  these  patients  showed  positive  SPT  reactions  and  IgE  antibodies  to  several
other fungal allergens and 75% to 80% had become sensitized to pet animal or pollen
allergens. The patients were mainly high IgE responders. The mean total IgE was 1632
kU/L in the patients while the atopic controls showed a mean total IgE level of 196 kU/L
with even lower values in the non-atopic controls, 61 kU/L.
The 40 mould sensitized patients were observed to also have IgE antibodies to a yeast
belonging to the normal skin flora ie. Pityrosporum ovale.  About 40% of the patients
demonstrated specific IgE antibodies to the P.ovale SPT extract in ELISA. The non-atopic
controls did not exhibit any IgE reactivity to P. ovale.
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SPT was repeated on the 40 mould sensitized patients selected for further studies using
commercial and an in-house (FIOH antigen) A. alternata allergen extract. The SPT results
were compared and showed a good correlation between the extracts (r=0.63). The
commercial and in-house fungal extracts exhibited also good correlation between the IgE
reactivity results measured by ELISA for both A. alternata (r=  0.99)  and C. herbarum
(r=0.92). In addition, CAP-FEIA and ELISA results correlated well for both the
commercial (ALK) and the in-house extracts. The correlation was r=0.91 for A. alternata
and r=0.88 for C. herbarum when commercial extracts were used. When the in-house
extracts were used, the correlation was 0.90 and 0.96 for A. alternata and C. herbarum
respectively. The control patients, that were atopic but not SPT positive to moulds and the
non-atopic individuals, had no IgE antibodies to either A. alternata or C. herbarum.
When the in vivo (SPT) and in vitro (specific IgE in sera) methods were compared no
correlation  or  only  a  poor  correlation  was  seen. A. alternata showed no correlation
between SPT using the commercial extract and specific IgE to either the commercial
(r=0.12) or the in-house extract (r=0.12). C. herbarum on the other hand, exhibited a poor
correlation between commercial SPT and specific IgE to the commercial (r=0.47) and the
in-house extract (r=0.63).
8.1.3. Characterization of cross-reacting components in mould and yeast
allergen extracts (II)
In order to investigate potential cross reactivity between mould and yeast allergen extracts,
ELISA  and  immunoblot  inhibition  assays  were  used.  Sera  showing  IgE  reactivity  to  all
three fungi (A. alternata, C. herbarum and P. ovale) were chosen for further studies. At
least two different binding patterns were seen in these patients. In some of the patients, the
binding was weakly (9%) or not at all inhibited by the other fungal extracts. This was
mostly seen in patients with high reactivity to one of the fungi studied but weak binding to
the other fungi. On the other hand, in patients with strong or intense binding to all fungi,
the binding was commonly inhibited by another fungal extract even as much as 100%.  In
some of these patient's sera, the IgE binding to a mould (C. herbarum or A. alternata) in
the solid phase was dose dependently inhibited by addition of the yeast P. ovale to the
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reaction and vice versa.  The immunoblot revealed that the inhibited part consisted mainly
of smeary bands indicating binding to carbohydrates.
The carbohydrate part was extracted from the yeast extract by ConA-Sepharose
chromatography which binds the mannosyl and glycosyl residues present in mannans and
glycoproteins in general. After the removal of the carbohydrate part from the yeast extract,
inhibition of binding to the mould extracts was markedly reduced in the majority of those
patients that previously had shown inhibition in ELISA and immunoblotting.
In addition, enzymatic deglycosylation was performed in order to specifically remove
N and O-linked carbohydrates from the yeast extract. However, after enzymatic
deglycosylation, cross-reactivity between the yeast and mould extracts was still seen. Part
of the cross-reactivity between mould and yeast extracts was therefore due to the binding
of IgE to the protein backbone in shared glycoprotein allergens.
8.2. Airway responses to mould spore exposure in experimental
models
8.2.1. Characterization of airway responses to S. chartarum (III)
Experimental models were used to investigate the role of satratoxins in the potential health
effects induced by S. chartarum spores. Two different strains, a satratoxin producing and a
non-producing strain were used at two different concentrations (103 and 105
spores/instillation). S. chartarum spores,  given  twice  a  week  for  a  total  of  three  weeks,
induced an airway inflammation characterized by a lymphocytic and neutrophilic cell
infiltration in the lungs of the mice at the higher spore concentration (105
spores/instillation). The lower dose (103 spores/instillation) did not induce any
inflammatory cell influx, the infiltrate was comparable to that seen in the control mice
receiving PBS alone. However, there was no major difference in the airway responses
evoked by the satratoxin producing compared to the non-producing strain.
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S. chartarum (105 spores/instillation) triggered an inflammatory infiltrate seen both in
the bronchoalveolar fluid as well as in the HE stained histological lung sections.
Macrophages predominated in the cell infiltrate with an increase in their number,
especially of neutrophils and lymphocytes, compared to the controls. Inflammatory cell
clusters were seen in the lung sections of S. chartarum exposed mice, mostly in the lung
parenchyma, but the inflammation was generally classified as mild.
The inflammatory infiltrate was accompanied by an increase in pro-inflammatory and
inflammatory cytokine and chemokine gene expressions in the lungs.  The pro-
inflammatory cytokines, IL-1 , IL-6 and TNF- , were induced in the lungs with both
strains when the higher spore concentration (105 spores per instillation) was used. The
inflammatory chemokines, CCL2/MCP-1, CCL-3/MIP-1  and CCL-4/MIP-1 , which
recruit inflammatory cells to site of inflammation, were also induced by both strains.
However, one chemokine, CXCL5/LIX, that attracts neutrophils, was induced more
strongly in mice that had received the satratoxin producing S. chartarum strain compared
to  the  non-satratoxin  producing  strain  although  the  difference  was  not  statistically
significant.
No signs of allergic sensitization to S. chartarum or  induction  of  airway
hyperresponsiveness were seen in this model. The airway responsiveness was measured
with whole body plethysmography two days after the final intranasal instillation of S.
chartarum spores. The response to methacholine, expressed as a change in the parameter
Penh, was not different from Penh values seen in the control mice. Serum IgE levels were
not significantly induced in S. chartarum exposed mice, neither were any mould specific
IgE, IgG1 nor IgG2a antibodies detected in the serum.
8.2.1. Modulation of experimental asthma by S. chartarum exposure (IV)
In order to investigate the role of the immunological status in relation to the airway
responses induced by exposure to S. chartarum, a well known allergic asthma model was
used together with exposure to spores. The allergic asthma model on its own induces a
Th2 type of allergic response with airway responsiveness, eosinophilia in the lung and IgE
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production against the sensitizing allergen.  The intranasal exposure to S. chartarum on
the other hand as shown in work III induces a neutrophilic inflammation with upregulated
levels  of  pro-  and  inflammatory  cytokines  and  chemokines  but  no  change  in  airway
responsiveness. When these two models were combined the inflammation was markedly
more severe although the airway responsiveness was decreased compared to the allergic
asthma model. Intranasal exposure to S. chartarum spores in conjuction with sensitization
and airway challenge to the allergen strongly enhanced the degree of airway inflammation
(Figure 7).
Figure 7 Percent of inflammatory infiltrates in mice lungs. PBS=control; OVA=OVA
sensitized/challenged; S. chart. = S. chartarum exposed; OVA+S.chart= OVA
sensitized/challenged and S. chartarum exposed; Sacc.c= mice exposed to bakers
yeast (Saccharomyces cerevisiae) and OVA+Sacc.c = OVA sensitized/challenged and
Sacc.c exposed. Results are expressed as mean ± SEM for each group. Significant
differences between the groups at **p<0.001, ns=not significant.
Sensitization and airway challenge to OVA induced the features associated with allergic
asthma. The OVA sensitized/challenged mice showed increased levels of Th2 type
cytokines such as IL-4, IL-5 and IL-13 in the lungs. The airway responsiveness to inhaled
methacholine was increased and IgE antibodies to OVA were found in sera. Histological
lung sections revealed the presence of inflammation mostly in the peribronchial areas and
the BAL showed that the eosinophils predominated in the infiltrate.
51
In ovalbumin sensitized/challenged mice which were also exposed to S. chartarum
spores, the total number of inflammatory cells was markedly increased and the cell
population had changed. The eosinophils still predominated as would be expected in this
allergic asthma model but at the same time increased numbers of neutrophils and
lymphocytes were seen in the inflammatory influx. The histological lung sections revealed
an inflammation which was seen both peribronchially and perivascularly. In addition
intense inflammation with granulomatous infiltrates and multinucleated giant cells was
seen in all compartments of the lung.
The intense inflammation in the lungs of OVA sensitized/challenged mice exposed to
S. chartarum was also seen as a strong induction in the levels of inflammatory and
especially the proinflammatory cytokines and chemokines.  TNF-  was markedly induced
both at the mRNA level in the lungs and at the protein level in BAL. The pro-
inflammatory cytokine, IL-1 , was also induced followed by increased levels of the
inflammatory chemokines CCL2/MCP-1 and CCL3/MIP-1  and their receptors CCR5 and
CCR3. MIP-2, which specifically recruits neutrophils to sites of inflammation in mice,
was also induced as was the levels of one of its receptors CXCR2.
The typical Th1 and Th2 cytokine mRNA expressions revealed mixtured features in
mice sensitized/challenged to OVA and exposed to S. chartarum.  Exposure to S.
chartarum in OVA sensitized/challenged mice showed a slight tendency to decrease the
levels of Th2 cytokines compared to the OVA sensitized/challenged mice while it slightly
increased the levels of IFN-  and IL-12p40 compared to either model on its own.
The airway responsiveness to methacholine was increased in OVA
sensitized/challenged mice but exposure to S. chartarum reduced the airway
responsiveness to the same level seen in S. chartarum exposed  alone.  IgE antibody was
produced to OVA in the OVA sensitized/challenged mice but the levels of the antibody
were not affected by exposure to S. chartarum.
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In  order  to  clarify  the  role  of  the  Th2  environment  on  the  induction  of  the
inflammation, splenocytes were isolated from OVA sensitized mice and stimulated in
vitro with S. chartarum spores. S. chartarum markedly increased the production of TNF-
and IL-1  mRNA expressions in splenocytes from OVA sensitized mice. The increase was




Exposure to increased levels of allergenic or toxic fungal spores has been considered to be
one of the major sources of the health problems linked to water damaged buildings. In this
thesis, different approaches to study the health effects associated with exposure to moulds
have been made. The prevalence of sensitization to moulds was studied in patients
attending the hospital for suspected allergy and was found to be low and highly dependent
on the atopic status of the exposed. In addition, part of the IgE binding to the mould
extract was shown to be due to cross-reactivity between moulds and yeasts. Sensitization
to moulds could therefore only explain part of the symptoms experienced in damp
buildings and therefore another approach using experimental models was taken. We
studied the airway responses to a toxin-producing damp building mould, Stachybotrys
chartarum, in an experimental model and found that it was able to induce airway
inflammation. Further, since individual variation in the symptoms has been observed upon
exposure, we hypothesized that the immunological status may play a role. We exposed
mice to S. chartarum in parallel to sensitization to an allergen and found that the degree of
airway inflammation was markedly enhanced.
9.1. Sensitization to moulds in patients
The prevalence of sensitization to moulds varies slightly, depending on the patient
material, climate and extracts used. The prevalence of sensitization to two of the most
commonly tested moulds in Finland was low (2.7% to Cladosporium herbarum and 2.8%
to Alternaria alternata).  In  Europe,  in  general,  the  prevalence  of  sensitization  to C.
herbarum and/or A. alternata in atopic subjects has been found to be on average 9.4% but
the prevalence does vary between countries with a rather wide range of frequencies e.g.
20% in Spain and 3% in Portugal (D'Amato et al. 1997). In the general population, the
median prevalence of specific IgE to C. herbarum was 2.4% in a large European
multicenter study (Burney et al. 1997) while positive skin test results to A. alternata in a
large US study were found in 3.6% of the sample (Gergen et al. 1987).
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The prevalence has been shown to be highly dependent on the population of patients
examined with higher frequencies being detected in atopic populations (Nolles et al.
2001). Atopic individuals commonly have high total IgE serum levels with weak IgE
reactivity to multiple allergens. Reactivity to several allergens in atopic individuals
indicates that they have undergone multiple sensitization events due to their increased
immunologic responsiveness (Aalberse et al. 2001). In our study, the majority of the
patients were atopics, indicating that the frequency of sensitization to moulds may be even
lower in the general population. In addition, it shoud be noted that the patients examined
for positive SPT results to  the whole fungal allergen panel comprised of selected
individuals due to indoor air problems. Therefore, although this subpopulation was
selected nonetheless the prevalence of positive SPT results to fungi remained low. The
low prevalence of specific IgE to fungi in the subpopulation suggests that the prevalence
might be low in the general population.
Sensitization to moulds seems to be rare but there are concerns that sensitized
individuals may be at an increased risk of developing allergic asthma (Bush and Prochnau
2004, Zock et  al. 2002). Epidemiological studies have pointed to an association between
mould sensitization and asthma, particularly for sensitization to Alternaria alternata
(Neukirch et al. 1999). In particular, the more severe form of asthma requiring emergency
ward treatment has been associated with sensitization to fungi (Black et al. 2000, Denning
et al. 2006). A European multicenter study showed that with increased severity of asthma,
the  frequency  of  sensitization  to  moulds  was  higher  in  all  regions  (Zureik et al. 2002).
This was clearly shown for the fungal species Cladosporium herbarum and Alternaria
alternata included in the test. A positive association was also seen between sensitization
to  house  dust  mite  (Dermatophagoides pteronyssinus) and asthma severity but no
association was seen for patients sensitized to pollen or cat allergens.
Reliable test methods and allergen extracts are needed to guarantee an accurate
diagnosis of fungal allergy. The fungal allergen extracts used in the clinic today are still
not well standardized (Esch 2004). The allergen composition may vary in extracts due to
different  strains,  growing  conditions  and  extraction  methods  used.   Thus,  the  mould
extracts show varying degrees of sensitivity and specificity. In our study, the correlation
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was good between the in-house and commercial extracts when the same methods were
used. On the contrary, the skin prick (in vivo) and ELISA (in vitro) allergy test results did
not correlate, this being especially the case for the A. alternata extracts. Commonly when
reliable and standardized extracts are used, there is an 85-95% correlation in the results
between SPT and IgE measurements in sera (Demoly et  al. 2003). SPT is the gold
standard method, and considered to be more reliable and specific than IgE measurements
(Dolen 2003). The poor correlation between the methods might be due to poor quality and
unknown biological activity of the mould allergen extracts used. On one hand, positive
skin prick tests results may be due to unspecific agents in the extract inducing histamine
release which is not IgE mediated. On the other hand, the ELISA methods may fail to
detect low levels of mould specific IgE in sera. The vast majority of the specific IgE has
been speculated to be bound to mast cells and Langerhans cell in the skin leaving only
trace amounts in sera.
9.2. Components in mould and yeast allergen extracts cross-
reacting for IgE binding
In  allergic  patients,  a  clustering  of  IgE  responses  to  fungal  allergens  has  often  been
observed (Potter et  al. 1991). It is more common to show reactivity to several fungal
species than for an individual to be sensitized to only one specific fungus (Mari et al.
2003).  Reactivity to multiple allergens may be due to a susceptibility or predisposition in
the individual to produce IgE to many different inhalant allergens or due to cross-
reactivity between the allergens (Aalberse et al. 2001).
One finding of special interest was that patients sensitized to moulds often also show
reactivity to a yeast present in the normal skin flora Pityrosporum ovale, synonymous to
Malassezia sp. (Nissen et al. 1998). It has been speculated that in atopic eczema where the
skin barrier is reduced due to itching and scratching of the skin, growth of the saprophytic
yeast Malassezia sp. might be favoured (Scheynius et  al. 2002). Increased levels of
Malassezia growth on the skin might induce the production of specific IgE antibodies to
the yeast in these patients (Jensen-Jarolim et al. 1992). Of our mould sensitized patients,
58% suffered from atopic eczema and about 40% showed IgE reactivity to P. ovale.
56
Potential cross-reactivity between the fungal extracts was studied and it was demonstrated
that mould and yeast extracts shared glycoproteins that cross-reacted for the IgE binding
in the sera of mould sensitized patients.
It is well known that moulds share some common allergens and species can cross-react
but also yeast species have shown cross-reactivity (Bisht et al. 2004, Kanbe et al. 1997).
Cross-reacting glycoproteins between mould and yeast allergen extracts have not however
previously been taken into account in evaluations of sera from atopic eczema patients.
Cross-reactivity has been observed for certain allergens between part of the moulds and
yeasts (Hemmann et  al. 1997). Aspergillus fumigatus and Candida albicans share
allergenic enzymes some of which seem to play a role as fungal virulence factors (Lopez-
Ribot et al. 2004). The inhibited or cross-reacting component in our study was not
however a specific band seen on the immunoblot. On the contrary, diffuse bands of size of
60-200 kDa indicated that shared high molecular weight glycoproteins may be present in
both mould and yeast extracts. It is known that yeasts contain allergenic mannans in their
cell wall but much less is known about the carbohydrates making up the mould cell wall.
Moulds,  especially  their  cell  walls,  do  contain  carbohydrates  as  well  and  some  of  the
mould allergens have been shown to be glycoproteins. The major allergen from Alternaria
alternata (Alt a1) and C. herbarum (Cla h2) are glycoproteins (Portnoy et al. 1998,
Sward-Nordmo et  al. 1988). The known glycoprotein allergens Alt a1 and Cla h2 are
however in the molecular weight range of 20-50 kDa in size.
The cross reactivity seen between mould and yeast allergen extracts (II) implies that
care should be taken when diagnosing allergy to moulds. Our results indicate that
individuals suffering from atopic eczema with specific IgE antibodies to P. ovale may also
show positive SPT results to moulds due to shared IgE binding glycoproteins in the
allergen extracts. Therefore some of the patients diagnosed as being sensitized to moulds
may indeed not be sensitized or allergic to moulds, but instead the primary sensitizer
might be the yeast. In our study, the yeast tended to show stronger inhibition of IgE
binding to moulds than vice versa indicating that P. ovale might be the primary sensitizer.
The role of antibodies to the saprophytic yeast on the skin in association with the
pathogenesis of atopic eczema is not clear (Faergemann 2002). Atopic eczema is a chronic
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inflammatory skin disease where allergens are thought to be involved in the maintenance
of the disease. High total IgE levels and antibodies to environmental allergens are
associated with this disease (Broberg et  al. 1992).  The  role  of  antibodies  to P. ovale is
hypothesized to be a contributing or triggering factor in the disease where there may be a
reduced skin barrier.  The cross-reactivity between moulds and yeasts for the IgE binding,
might therefore exaggerate atopic eczema upon exposure to moulds. These factors need to
be taken into account when diagnosing mould allergy, especially if the patient also suffers
from atopic eczema.
Taken together these results suggest that mould allergy seems to be rare. The clinical
significance of the positive results to fungal allergen extracts can further be questioned
due to the cross-reactivity seen between extracts. Mould allergy appears to explain only
part of the symptoms experienced by occupants of damp buildings, suggesting that other
non-allergic factors and responses may be involved. We therefore chose one specific damp
building mould that frequently has been implicated in the literature as a potential inducer
of health problems, Stachybotrys chartarum, and studied the airway responses to this
mould in experimental models. With the chosen mould, other non-IgE mediated
mechanisms related to exposure to fungi were investigated.
9.3. Airway responses to exposure to S. chartarum spores in an
experimental model
Stachybotrys chartarum is a damp building mould that is recognized for its ability to
produce highly toxic secondary metabolites such as macrocyclic trichothecenes under
suitable conditions (Jarvis et al. 1998). There are several macrocyclic trichothecenes, but
satratoxins have been shown to be some of the most potent (Yang et al. 2000). A
satratoxin producing and a non-producing strain of S. chartarum in two different
concentrations were used in study III in order to study the effects of the microbe in the
airways of mice.
Intranasal instillations of spores from both the satratoxin producing and the non-
producing strain of Stachybotrys chartarum induced inflammation in the airways with
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almost no difference between the strains. Although Stachybotrys-produced trichothecenes,
satratoxins, have been shown by others to induce changes in the phospholipid composition
of pulmonary surfactants (Mason et al. 1998, Rand et al. 2002) as well as the erythrocyte
accumulate in the lungs (Rao et al. 2000, Yike et al. 2002), it is possible that other
components of the secondary metabolites induced the airway inflammation seen here.
Similar results were recently reported in a study using two different Stachybotrys strains,
one of which was a trichothecene producer and the other an atranone producer (Flemming
et al. 2004). Both strains triggered similar kinds of airway responses according to the cell
population seen in BAL when low spore doses were used. Other biologically active
components in addition to the trichothecenes might be involved, especially atranones and
hemolysins have gained much attention lately (Miller et al. 2003).  Atranones might be
potential inducers of inflammation via activation of macrophages (Nielsen et al. 2002)
while hemolysins on the other hand might play a role in causing haemolytic effects such
as haemorrhage (Vesper and Vesper 2002).
In addition there are other, non-toxic components that might trigger or enhance the
inflammatory effects in the airway. Fungal cell wall constituents such as (1 3)-D-
glucan and the recently recognized proteases are potential agents inducing inflammation
(Rylander and Lin 2000). Fungal spores or conidia as well as hyphae from the pathogenic
fungi Aspergillus fumigatus have been shown to bind to TLR2 and 4 and trigger the
induction of pro-inflammatory cytokines in macrophage cell lines (Bellocchio et al. 2004).
In the case of the pathogenic yeast Candida albicans, the component to which TLRs 2, 4
and 6 bind is a yeast cell wall mannan,  phosholipomannan (Jouault et  al. 2003). On the
other hand, -glucan has recently been found to be a potent inducer of the innate immune
system also via other receptors such as Dectin-1 (lectin receptor for -glucan) (Gantner et
al. 2003). In addition it has been found that the proteases produced by the fungi may play
an important perhaps adjuvant roles, e.g. proteases have recently been found to potentially
favour the uptake of fungal spores into host cells (Reed and Kita 2004). A protease
produced by Stachybotrys, called stachyrase A, is known to cleave structurally important
proteins such as collagen in the lung environment (Kordula et al. 2002).
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In order to mimic long term exposure the fungal spores were installed twice a week for
a total three weeks. Two concentrations were used, 103 and 105 spores per instillation,
these being chosen based on previous experience. By taking into account the lung volumes
and breathing frequencies of mice in comparison to human lungs, estimations were made
of potentially inhaled spore concentrations (Nikulin 1999). With intratracheal instillations,
it is usual to assess the acute responses and concentrations ranging from 5x102 to 5x105 of
Stachybotrys spores have been administered to mice (Flemming et al. 2004, McCrae et al.
2001). Instillations of spore concentrations above 105 are considered too high in relation to
real-life exposure (Miller et al. 2003).  However, with intranasal instillations, the exact
amount of spores reaching the lungs cannot be estimated precisely. Part of the spores will
stay in the nose and some are swallowed (Southam et al. 2002). It has been estimated that
only 1/10 or perhaps as little as 1/50 of the spores ultimately reach the lungs after
intranasal instillation (McCusker et  al. 2002). With intranasal instillations performed
repeatedly however, the variation between the mice and groups will be minimized and
comparisons between the groups can be made.
There were no signs of allergy or sensitization to S. chartarum using this model.
Stachybotrys spores or its allergenic extracts may also induce sensitization in experimental
settings (Viana et al. 2002). Specific antibodies to S. chartarum have been found in patient
studies and some of the allergens has been characterized (Barnes et al. 2002, Karkkainen
et al. 2004). However, the airways in general or the intranasal instillations used here is not
the most effective route to induce sensitization in experimental settings. Furthermore, the
airway responsiveness did not increase after S. chartarum exposure in this model.  More
frequent instillations or alternatively sensitization (i.p. injections) and airway challenge
using more allergenic spores might have been needed to induce allergic asthmatic
reactions to mould spores and AHR.
9.4. Airway inflammation in OVA allergic mice exposed to S.
chartarum
Exposure to damp buildings evokes a variety of poorly defined symptoms which are not
easy to diagnose. Individuals seem to respond differently to the same exposure, implying
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that the immunological status might play a role (Kauffman and Van Der Heide 2003).
Exposure to a damp building mould might affect differently an individual with unbalanced
immunity  such  as  an  atopic  person.  To  study  this  phenomenom,  a  well  known  allergic
asthma model was used together with exposure to S. chartarum (IV). When mice were
both sensitized/challenged to an allergen (OVA) and exposed to S. chartarum spores, the
extent of inflammation in the lungs was markedly increased, evidence of a clear
interaction between the responses.
The enhanced inflammation seen in work IV suggests that the lungs were more
susceptible to exposure to S. chartarum when the mouse had been sensitized to an
allergen. As previously shown, without allergic asthma, S. chartarum was normally
cleared from the lungs through the phagocytosing actions of macrophages and neutrophils,
inducing only a mild inflammation (III). However, a severe inflammation was seen when
allergen sensitization was employed together with exposure to S. chartarum (IV). The
histological lung sections showed intense inflammatory infiltrates that were not seen in
any of the individual models. In order to determine whether the Th2 environment had
enhanced the inflammation to S. chartarum, OVA sensitized splenocytes were stimulated
with S. chartarum in vitro. Th2 primed splenocytes did induce higher pro-inflammatory
cytokine mRNA compared to the non-primed naive cells when stimulated with S.
chartarum. The results imply that in an allergic Th2 type of environment, exposure to S.
chartarum evokes a more severe inflammation.
The results also suggest that if the lungs are experiencing an ongoing Th2 type
inflammation, then they may be more vulnerable and incapable of defending themselves
against new invaders such as microbes. This can lead to the gathering of microbes into
inflammatory clusters in macrophages which are typical of a disease condition called
allergic alveolitis. The inflammation seen in the histological lung sections (IV) contained
multinucleated giant cells and granuloma formation as is also seen in patients with allergic
alveolitis. Extrinsic allergic alveolitis develops when intracellular particles or micro-
organisms that the cell has not been able to destroy are gathered into activated
macrophages which then become transformed into epitheloidal cells. The epitheloidal cells
secrete increasing amounts of TNF-  in order to destroy the agent but this leads to
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increased inflammation and the formation of giant cells and granulomatous inflammation
in the lung (Roitt et al. 2001). Exposure to S. chartarum has been shown also to induce
granuloma formation in mice lungs in a direct manner (Rand et al. 2003). However, in our
model, sensitization/challenge to OVA was needed to induce this condition after exposure
to S. chartarum.
Surprisingly, the airway hyperresponsiveness (AHR) was reduced in OVA
sensitized/challenged mice also exposed to S. chartarum. Microbes or microbial products,
especially bacteria, have been shown to modulate the airway inflammation and AHR in
allergic mice (Hopfenspirger and Agrawal 2002). The decrease or increase in AHR has
correlated with the degree of inflammation related to eosinophils and to the pulmonary
levels  of  mediators  such  as  IL-13  and  IL-5  (Instanes et al. 2004). In our study, the
inflammatory response in the lung was not reduced. We speculate that the effect on AHR
might be due to the slight decrease in IL-13 and to some extent to the other Th2 cytokines
(Wills-Karp et al. 1998). Another possibility is that the whole body plethysmography
(Buxco system) used to measure airway responsiveness in conscious unrestrained mice,
was not sensitive enough to recognize the airway changes occuring here. A parameter
called enhanced pause (Penh) is calculated based on the pressure in the chamber in
relation to breathing patterns of the animal (Hamelmann et al. 1997).  However,  it  is  still
unclear whether this parameter actually reflects airway responsiveness and changes in
lung function (Albertine et al. 2002, Bates and Irvin 2003, Lundblad et al. 2002).
Therefore our results related to airway responsiveness have to be interpreted with caution.
A more sensitive invasive method measuring airway resistance in anaesthetized animals
might be needed in order to confirm if the decrease in Penh indeed is related to a change in
airway function.
These results imply that sensitized individuals may be at a higher risk of developing
health problems if they are exposed to moulds such as Stachybotrys chartarum, compared
to non-sensitized individuals. The health effects associated with damp buildings might be
highly dependent on the immunological status of the exposed. This is an interesting
finding that may shed some light on why the symptoms associated with exposure to damp
buildings seem to exhibit such inter-individual variation. Patient studies in damp buildings
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have indeed revealed a higher risk of respiratory symptoms in atopic children (Verhoeff et
al. 1995). The risk increased with maternal asthma pointing to a potential difference in
susceptibility to exposure in atopic children (Belanger et al. 2003). It may further be
hypothesised that individuals suffering from other diseases disturbing the normal immune
response (allergy, rheumatic diseases, immunosuppression) might be more susceptible to
the inflammatory effects of moulds. There are some indications that this might be the case
i.e. a recent report described a clustering of rheumatic type of diseases in moisture
damaged work-places (Luosujarvi et al. 2003, Myllykangas-Luosujarvi et al. 2002).
Healthy individuals on the other hand, are probably able to handle exposure to at least low
levels of mould spores without suffering any serious health problems and symptoms.
However, if the exposure is long-lasting and the spore levels are high, then health
problems may arise even in healthy individuals.
Although  our  results  rely  on  experimental  exposure  studies  only,  it  is  realistic  to
believe that exposure to high levels of either allergenic or potentially toxic moulds might
induce health problems in susceptible individuals. High levels of airborne fungal spores
can occasionally be found in damp buildings and be responsible for health problems. In
these cases, although allergy to moulds does seem to be rare, attention should be paid to
sensitized individuals who may develop allergy and worsening of asthma symptoms. In
addition, if moulds that are known to produce potentially harmful secondary metabolites
are found in large amounts in the building, especially if high spore levels containing toxins
are found in the air, then remedial actions need to be taken. Exposure to high levels of the
damp building mould Stachybotrys chartarum should be avoided. Although the
trichothecene, satratoxin, did not enhance the airway inflammation seen here in relation to
the strain not producing satratoxin there is a body of evidence indicating that the mould is
not innocuous. Stachybotrys, even without satratoxins, clearly induced a more severe




In the future improved and standardized allergen extracts will be needed in order to
diagnose allergy or sensitization to moulds accurately. The diagnosis of asthma and other
hypersensitivity disorders depends on the availability of reliable allergy tests. Mould
allergen extracts are a problem for the manufacturers of these products as well as for the
clinician performing the allergy tests. Many attempts have been made in order to improve
the quality of the extracts. Pure recombinant fungal allergens have shown promising
results in allergy diagnosis, but much more work is needed to identify all the moulds and
the allergens that might induce sensitization in susceptible individuals. Reliable allergy
tests would, at least, help to identify those sensitized individuals.
As a model organism, to study the non-allergic airway responses to a damp building
mould, Stachybotrys chartarum was used in the second part of the thesis. The results from
the experimental model revealed that S. chartarum, may be considered a harmful mould if
an individual is exposed to it at high concentrations. Many of the health problems linked
to exposure to S. chartarum have been considered to be attributable to the produced
trichothecenes. However, recent findings have recognized many other components in the
cell wall that may be extremely important. More detailed studies into the mould wall
components could reveal the most potent components involved in the induction of
inflammation. One intriguing question concerns the interaction and potential co-operation
between these components and metabolites i.e. can they facilitate each other's actions. It is
known that microbes in general and pathogens in particular have developed sophisticated
ways to avoid elimination by the host's defence system.
The mechanism behind the development of enhanced airway inflammation in allergic
mice exposed to S. chartarum needs to be investigated in more detail. It was of interest to
note that the airway inflammation in these mice resembled the disease condition extrinsic
allergic alveolitis. Extrinsic allergic alveolitis has occasionally been seen in patients
exposed to high levels of moulds. It is more commonly found in farmers handling mouldy
hay but also some cases associated with damp buildings have been reported (Schwarz et
al. 2000, Trout et al. 2001). Detailed studies are needed to identify the potential cells
involved in the development of the inflammation. If the inflammation indeed resembles
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extrinsic allergic alveolitis, then macrophages might play a major role. Stimulation of
macrophages with S. chartarum in a Th2 environment might give initial clues to the
process. In addition, since both a Th2 type of response and an innate response are induced,
the interaction and the early phase of regulation of these responses might be the key
inducers determining the final effect. A more detailed knowledge about the mechanism
behind the inflammation could help to identify and potentially to treat some of the
symptoms in order to dampen the overall effect. For example, if the allergic symptoms
could be treated or dampened, the overall effect of the potential inflammation might be
reduced.
In this thesis the airway responses to one damp building mould were studied but more
attention should be paid to the other microbes, also non-toxic micro-organisms, present in
the damp building and their possible interactions. A synergistic interaction between
bacteria (Streptomyces) and Stachybotrys has been observed in macrophage cell lines
inducing enhanced levels of inflammatory markers such as IL-6 (Huttunen et  al. 2004,
Penttinen et al. 2005). Many different microbes including bacteria and moulds with
potential health effects may be living on damp material. Our present knowledge about
microbes indicates that indeed a variety of health effects may occur, depending on the
mould species and their numbers. Microbes may trigger allergic, inflammatory,
immunostimulatory or immunosuppressive health effects. The final outcome of health
problems experienced by occupants of damp buildings can therefore be a mixture of all of
these responses. At the moment one microbe at a time has been tested for its potential
health effects and this is the best way to start to assess their effects. In the future however,
all the microbes found in the damp building will need to be taken into account when
evaluating the potential health effects.
There are still many controversies in the field of damp building moulds and the health
effects linked to these buildings. Fungi and their role as potential inducers of health
problems in water damaged buildings have frequently been debated in the media during
the last ten years.  Different opinions exist, even among clinicians and therefore patients
with health problems assumed to be related to a damp building are treated very differently.
This is understandable especially since there are few, if any, markers to be used to
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measure exposure in patients. Nonetheless, it is important to take into account the fact that
there are likely individual differences in the health effects experienced in damp buildings.
Therefore every damp building case should be treated as unique, depending on the
microbes found and the patients involved.
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10. CONCLUSIONS
The prevalence of sensitization to two commonly tested fungal species, Cladosporium
herbarum and Alternaria alternata was found to be low in a Finnish population.
Sensitization to fungi was mostly observed in patients suffering from atopic diseases such
as atopic dermatitis, asthma and rhinitis. The patients were commonly sensitized to other
inhalant allergens as well, such that specific sensitization to moulds seems to be of minor
clinical importance.
Shared IgE binding glycoproteins in mould and yeast allergen extracts were detected in
some of the mould sensitized patients sera. The majority of the patients sensitized to
moulds suffered from atopic eczema. Atopic eczema patients, on the other hand, have
often been observed to have antibodies in their sera to a yeast found on the skin
Pityrosporum ovale.  In  this  study,  cross-reactivity  between  the  mould  and  the  yeast
allergen extracts used in skin prick testing was observed. The cross-reactivity was found to
be due to IgE binding to shared glycoproteins in the extracts. This should be taken into
account  if  patients  are  considered  to  suffer  an  allergy  to  moulds,  in  order  to  avoid  false
positive results, especially in atopic dermatitis patients.
Stachybotrys chartarum is one of the most widely studied moulds associated with
damp buildings due to its capability to produce a variety of highly toxic trichothecenes.
Exposure to Stachybotrys chartarum induced an airway inflammation in mice. The airway
inflammation was characterized by a neutrophilic and lymphocytic lung infiltrate. The
trichothecenes, satratoxin G and H, did not appear however to be responsible for the
inflammation induced in the airways measured here. Other components of the spores seem
to also play a role. This study has added new useful information concerning the airway
inflammation and the potential components involved in the airway inflammation induced
by Stachybotrys chartarum.
The immunological status of the exposed individual seems to play an important role in
determining the health effects and this has not been previously recognized. When mice
were both sensitized/challenged to an allergen (OVA) and exposed to Stachybotrys spores,
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then the inflammation detected in the lungs was markedly enhanced. The histological lung
sections showed intense inflammatory infiltrates, evidence of a strong interaction between
the  responses.  These  results  suggest  that  an  atopic  person  might  be  at  higher  risk  to
develop airway inflammation or symptoms from exposure to a damp building compared to
a non-atopic individual.
The results in this thesis indicate that exposure to certain moulds indoors might trigger
health effects in susceptible individuals. One of the potent candidates to induce health
problems in water damaged buildings is Stachybotrys chartarum. The symptoms
experienced by some occupants of these buildings are most probably not attributable to
IgE mediated allergy. In this thesis we have found new explanations, by using
experimental models, for an inflammatory reaction in the airways induced by moulds.
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